Document:

EX-10.37

 Exhibit 10.37 

FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT 

THIS FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (“Amendment”) is dated as of December 11, 2013, and is made by and
among: 
 (a) Hospitalist Management Consultants of New York, Inc., a New York corporation (“Buyer”); 

(b) InPatient Hospitalist Services of New York, P.C., a New York professional service corporation (“PC Buyer”) (each of Buyer
and PC Buyer an “Acquiror” and, together, “Acquirors”); 
 (c) Park Avenue Health Care Management, LLC, a
New York limited liability company (“Management Seller”); 
 (d) Park Avenue Medical Associates, P.C., a New York
professional service corporation (“PC Seller”) (each of Management Seller and PC Seller, a “Seller” and collectively, “Sellers”); and 

(e) the individuals listed on Exhibit A of the Asset Purchase Agreement, dated October 23, 2013 (the “APA”) (each
such individual an “Owner” and, collectively, “Owners”; Owners, the trust listed on Exhibit A of the APA, and Sellers are referred to herein collectively as “Selling Group”). 

Acquirors and Selling Group entered into the APA, under the terms of which Acquirors will purchase upon the Closing Date certain of the assets
of Selling Group, including the Owners’ Personal Goodwill, in return for cash and other consideration. Acquirors and Selling Group now wish to amend the APA as set forth below. All capitalized terms not otherwise defined herein shall have the
meaning ascribed to them in the APA unless the context otherwise requires. 
 NOW THEREFORE, in consideration of the promises and respective
covenants and agreements contained herein, the parties hereby agree, effective the date hereof, as follows: 
  

	1.	Section 1.10(a)(i), commencing on line five of Section 1.10(a), is deleted in its entirety and replaced with the following: 

“(i) the Liabilities arising subsequent to the Closing Date or the Assignment Date (as defined herein) as set forth in Schedule
1.10 and the Liabilities arising prior to the Closing Date to perform services after Closing pursuant to the Revenue Contracts (as defined in Schedule 1.1 and regardless of the Assignment Date) and any other contracts being assumed as set
forth on Schedule 1.1, and all other Liabilities under the Revenue Contracts, but only to the extent each of the other Liabilities is incurred after the latter of the Closing or the date such contract was actually assigned to PC Buyer (the
“Assignment Date”);” 

  

	2.	Section 2.1(aa) is deleted in its entirety and replaced with the following: 

“(aa) Sellers shall have delivered to Acquirors a certificate of the President of each Seller, in form and substance satisfactory to
Acquirors, certifying that Sellers or Sellers’ Affiliates shall have paid in full at or prior to the Closing all amounts owed under or arising from the following: (i) the Corporate Integrity Agreement (other than the costs of complying
with the Corporate Integrity Agreement following the Closing), (ii) the Confidential Settlement Agreement and General Release of Claims, dated July 2, 2013 by and between Sellers and their Affiliates and Zachary Wolfson, (iii) the
Stipulation and Order of Settlement and Dismissal by and among the State of New York, Sellers and their Affiliates, and relator Zachary Wolfson, dated July 15, 2013, and (iv) the Stipulation and Order of Settlement between United States of
America, PC Seller, Management Seller, and relator Zachary Wolfson, dated July 9, 2013.” 
  

	3.	Section 5.14 is hereby deleted in its entirety and replaced with the following: 

“5.14 Corporate Integrity Agreement Implementation; Dismissal/ Settlement of State Claims. Sellers shall cooperate fully with
Acquirors in implementing and complying with the Corporate Integrity Agreement and in carrying out any ongoing obligations under the Confidential Settlement Agreement and General Release of Claims, dated July 2, 2013 by and between Sellers
and their Affiliates and Zachary Wolfson, the Stipulation and Order of Settlement and Dismissal by and among the State of New York, Sellers and their Affiliates, and relator Zachary Wolfson, dated July 15, 2013, and the Stipulation and Order of
Settlement between United States of America, PC Seller, Management Seller, and relator Zachary Wolfson, dated July 9, 2013.” 
  

	4.	The APA shall be amended to add the following new Section 5.17, Assignment of Agreements. 

“5.17 Assignment of Agreements. Notwithstanding Section 2.1(m) herein, within sixty (60) days after the Closing,
the Selling Group shall cause those certain (i) Medical Services Agreement by and between PC Seller and Bronx-Lebanon Hospital Center, dated February 1, 2013; (ii) Services Agreement by and between PC Seller and Daughters of Jacob,
dated July 14, 2000; (iii) Practitioner Services Agreement by and between PC Seller and Jewish Home Lifecare, Manhattan, dated May 1, 2012; and (iv) Amended and Restated Administrative and Professional Services Agreement by and
between PC Seller and St. Luke’s Roosevelt-Hospital Center, dated November 20, 2010; that were not assigned to PC Buyer at or prior to Closing to be either (a) terminated; (b) assigned to PC Buyer on terms reasonably acceptable
to PC Buyer; or (c) terminated and a new agreement, on terms reasonably acceptable to PC Buyer, entered into by PC Buyer for the same services. Further, PC Seller represents that it has been operating under a written agreement with Concourse
Rehabilitation & Nursing Center (“Concourse”), but PC Seller and 

  
 -2- 

 
Concourse have been unable to locate an executed copy of the agreement. Within sixty (60) days after the Closing, PC Seller shall either (x) locate the executed agreement with
Concourse, and PC shall cause the agreement to be assigned to PC Buyer on terms reasonably acceptable to PC Buyer; or (y) shall cause the current arrangement between Concourse and PC Seller to be terminated and a new agreement, on terms
reasonably acceptable to PC Buyer, entered into by PC Buyer for the same services.” 
  

	5.	The APA shall be amended to add the following new Section 5.18, Continuation of Medical Services Agreements: 

“5.18 Continuation of Medical Services Agreements. For a period of time not to exceed thirty (30) days following the Closing
Date, or until such time when the Professional Corporations (as defined herein) enter into new medical services agreements with PC Buyer, whichever is earlier (the “Interim Period”), PC Seller shall be permitted to continue to
contract with Pulmonary Care Associates, P.C., Electrophysiologic Medical Diagnostics, P.C., and Veronica Zak Medical PC (the “Professional Corporations”) for certain medical services. PC Seller’s contracting with the
Professional Corporations to provide professional medical services during the Interim Period shall not be a violation of the PC Seller Noncompetition Agreement. All billings and revenue related to all professional services provided by the
Professional Corporations during the Interim Period shall be the sole and exclusive property of PC Seller and shall not be included in the Earnout Calculation, and PC Seller shall be responsible for any and all obligations to the Professional
Corporations and any and all Liabilities relating to or arising from any written agreements between PC Seller and the Professional Corporations.” 
  

	6.	Section 6.2(a)(ii), commencing on line five of Section 6.2(a), is hereby deleted in its entirety and replaced with the following: 

“(ii) the Excluded Liabilities, including any Liabilities relating to or arising from any Revenue Contracts that are incurred prior
to the Closing Date or the Assignment Date;” 
  

	7.	Sections 6.2(a)(xiv) and (xv), commencing on line seventeen of page 35 of the APA, are hereby deleted in their entirety and replaced with the following: 

“(xiv) any Liability arising from or relating to the Confidential Settlement Agreement and General Release of Claims, dated
July 2, 2013 by and between Sellers and their Affiliates and Zachary Wolfson; (xv) any Liability arising from or relating to the Stipulation and Order of Settlement and Dismissal by and among the State of New York, Sellers and their
Affiliates, and relator Zachary Wolfson, dated July 15, 2013, or the Stipulation and Order of Settlement between United States of America, PC Seller, Management Seller, and relator Zachary Wolfson, dated July 9, 2013.” 

  
 -3- 

	8.	The “Disclosure Schedules” are hereby deleted in their entirety and replaced with the “Amended and Restated Disclosure Schedules” attached hereto. 

 

	9.	This Amendment may be executed in any number of counterpart signature pages each of which shall be deemed to be an original and all of which together shall constitute one and the same original instrument. This Amendment
and its counterparts may be executed and delivered by facsimile transmission with confirmation of received transmission or other electronic means that faithfully reproduces the original with same effect as if a manually signed original were
personally delivered. 

  

	10.	This Amendment is hereby attached to and made part of the APA and subject to all provisions of the APA not in conflict with the provisions of this Amendment. In the event inconsistencies or ambiguities arise between
this Amendment and the APA, this Amendment shall supersede and control. All other provisions not amended by this Amendment shall remain in full force and effect. 

(Signature Pages Follow) 

  
 -4- 

 IN WITNESS WHEREOF, the parties have caused this Amendment to be duly executed as of the day and
year first above written. 
  

			
	PC BUYER:	 	 INPATIENT HOSPITALIST
 SERVICES OF
NEW YORK, P.C.

		
	Address for Notice:	 	  

	 4605 Lankershim Blvd., Suite 617
 North
Hollywood, CA 91602
 Attention: Chief Executive Officer
 FAX:
818-766-9781
	 	 Adam Singer, M.D.
 President

		
	with a copy to (which shall not constitute notice):	 	
		
	 4605 Lankershim Blvd., Suite 617
 North
Hollywood, CA 91602
 Attention: Vice President of Legal Affairs

FAX: 818-509-8186
	 	

 (PC Buyer’s Signature Page to First Amendment to Asset Purchase Agreement) 

  
 S-1 

 IN WITNESS WHEREOF, the parties have caused this Amendment to be duly executed as of the day and
year first above written. 
  

			
		
	BUYER:	 	 HOSPITALIST MANAGEMENT
 CONSULTANTS
OF NEW YORK, INC.

	 Address for Notice:
  
	 	  

	 4605 Lankershim Blvd., Suite 617
 North
Hollywood, CA 91602
 Attention: Chief Executive Officer
 FAX:
818-766-9781
	 	 Adam Singer, M.D.
 President

		
	with a copy to (which shall not constitute notice):	 	
		
	 4605 Lankershim Blvd., Suite 617
 North
Hollywood, CA 91602
 Attention: Vice President of Legal Affairs

FAX: 818-509-8186
	 	

 (Buyer’s Signature Page to First Amendment to Asset Purchase Agreement) 

  
 S-2 

 IN WITNESS WHEREOF, the parties have caused this Amendment to be duly executed as of the day and
year first above written. 
  

			
		
	PC SELLER:	 	 PARK AVENUE MEDICAL
 ASSOCIATES,
P.C.

		
	Address for Notice:	 	  

	 3 Barker Avenue
 White Plains, New York
10601
 Attention: President
	 	Mitchel Kaplan, M.D., President
		
	 with a copy to
	 	
	(which shall not constitute notice):	 	
		
	 Garfunkel Wild, P.C.
 111 Great Neck Road

Great Neck, New York 11021
 Attention: Judith Eisen, Esq.

FAX: 516-466-5964
	 	

 (PC Seller’s Signature Page to First Amendment to Asset Purchase Agreement) 

  
 S-3 

 IN WITNESS WHEREOF, the parties have caused this Amendment to be duly executed as of the day and
year first above written. 
  

			
		
	MANAGEMENT SELLER:	 	 PARK AVENUE HEALTH CARE

MANAGEMENT, LLC

		
	Address for Notice:	 	  

	 3 Barker Avenue
 White Plains, New York
10601
 Attention: President
	 	Brad Markowitz, President
		
	with a copy to	 	
	(which shall not constitute notice):	 	
		
	 Garfunkel Wild, P.C.
 111 Great Neck Road

Great Neck, New York 11021
 Attention: Judith Eisen, Esq.
	 	
	FAX: 516-466-5964	 	

 (Management Seller’s Signature Page to First Amendment to Asset Purchase Agreement) 

  
 S-4 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the day and
year first above written. 
  

			
	OWNERS:	 	
		
	 Address for notice:
  
	 	  

	 3 Barker Avenue
 White Plains, New York
10601
	 	Mitchel Kaplan, M.D., as an individual
		
	 Address for notice:
  
	 	  

	 3 Barker Avenue
 White Plains, New York
10601
	 	Mitchell Wolfson, M.D., as an individual
		
	 Address for notice:
  
	 	  

	 3 Barker Avenue
 White Plains, New York
10601
	 	Joel Blass, M.D., as an individual
		
	 Address for notice:
  
	 	  

	 3 Barker Avenue
 White Plains, New York
10601
	 	Daniel Sussman, M.D., as an individual
		
	 Address for notice:
  
	 	  

	 3 Barker Avenue
 White Plains, New York
10601
	 	Brad Markowitz, as an individual
		
	with a copy for all (which shall not constitute notice) to:	 	
		
	 Garfunkel Wild, P.C.
 111 Great Neck Road

Great Neck, New York 11021
 Attention: Judith Eisen, Esq.

FAX: 516-466-5964
	 	

 (Owners’ Signature Page to First Amendment to Asset Purchase Agreement) 

  
 S-5 

 AMENDED AND RESTATED DISCLOSURE SCHEDULES 

Attached. 

  
 S-6EX-10.38

 Exhibit 10.38 

FINAL 
 ASSET
PURCHASE AGREEMENT 
 THIS ASSET PURCHASE AGREEMENT (“Agreement”), dated as of October 23, 2013, is made by
and among: 
 (a) Hospitalists Management of New Hampshire, Inc., a New Hampshire corporation qualified to do business in Massachusetts and
Connecticut (“Buyer”); 
 (b) IPC Hospitalists of New England, P.C., a New Hampshire professional service corporation
qualified to do business in Massachusetts and Connecticut (“PC Buyer”) (each of Buyer and PC Buyer an “Acquiror” and, together, “Acquirors”); 

(c) Park Avenue Medical Associates, LLC, a Connecticut limited liability company qualified to do business in Massachusetts and Vermont
(“Seller”); and 
 (d) the individuals listed on Exhibit A (each such individual an “Owner” and,
collectively, “Owners”; Owners and Seller are referred to herein collectively as the “Selling Group”). 

This Agreement contemplates a transaction in which Acquirors will purchase certain of the assets of Seller comprising Seller’s Business,
including the Owners’ Personal Goodwill, in return for cash and other consideration. Terms used in this Agreement that are capitalized or otherwise have special meaning have the definitions given to such terms in Section 8.9 and
elsewhere in the Agreement. 
 NOW THEREFORE, in consideration of the promises and respective covenants and agreements contained herein, and
for good and valuable consideration the receipt of which is acknowledged, the parties hereby agree as follows: 
 ARTICLE I 

PURCHASE AND SALE OF ACQUIRED ASSETS; CLOSING 

1.1 Purchase and Sale. Upon and subject to the terms and conditions hereof, Seller sells, conveys, transfers and assigns to Buyer, and
Buyer purchases and accepts from Seller, free and clear of all Liens and effective at 12:01 a.m. Eastern Daylight Time on the Closing Date (as defined in Section 1.9), all right, title and interest in and to all of the assets of Seller
listed on Schedule 1.1 as the “Acquired Assets” (hereinafter, the “Acquired Assets”), but not any of the PC Acquired Assets (as defined in this Section 1.1) or any of the Excluded Assets (as defined
in Section 1.2). Upon and subject to the terms and conditions hereof, Seller sells, conveys, transfers and assigns to PC Buyer, and PC Buyer purchases and accepts from Seller, free and clear of all Liens and effective at 12:01 a.m.
Eastern Daylight Time on the Closing Date, all right, title and interest in and to all of the assets of Seller listed on Schedule 1.1 as the “PC Acquired Assets” (hereinafter, the “PC Acquired Assets” and, together
with the Acquired Assets, the “Purchased Assets”), but not any of the Acquired Assets or any of the Excluded Assets. 
 1.2
Excluded Assets. The “Excluded Assets” consist of all assets, properties and rights of Seller are not specifically set forth in Schedule 1.1, including, but not limited to the

 
assets, properties and rights listed on Schedule 1.2, and any of the following: Seller’s Medicare or Medicaid provider numbers; cash and accounts receivable of Seller, except for cash
and/or receivables related to services to be provided after the Closing; any patient medical records or other protected health information; and original minute books and other corporate and financial records. 

1.3 Non-Transferability of Certain Contracts; Assignment of Contracts. Nothing in this Agreement shall be construed as an attempt to
assign any contract, agreement, permit, franchise or claim included in the Purchased Assets (each a “Contract”) which is, by its terms or Law non-assignable without the consent of the other party or parties thereto, unless such
consent shall have been given or as to which all the remedies for the enforcement thereof enjoyed by Seller would, as a matter of law, pass to Acquirors as an incident of the assignments provided for by this Agreement. Seller shall, both before and
after the Closing, upon the specific request of Acquirors, use best efforts to obtain the consent of the other party to the assignment to Acquirors, of any Contract for which such consent is required. In the event (a) a Contract either does not
permit or expressly prohibits the assignment by Seller of its rights and obligations thereunder; or (b) Seller has not obtained the necessary consents to assignment from all parties to any Contract prior to the Closing Date, Acquirors will
fulfill such Contract and shall assume the obligations and liabilities (arising after the Closing Date) of such Contract for and on behalf of Seller but for the account of Acquirors and, in such event, Seller shall cooperate with Acquirors in any
reasonable arrangements designed to provide for Acquirors all of the revenues and other benefits under such Contracts including the enforcement for the benefit and at the expense of Acquirors of any rights previously enjoyed by Seller in connection
with such Contracts, to the extent permissible under applicable Laws and regulations. 
 1.4 Purchase Price. The purchase price to be
paid by Acquirors for the Purchased Assets (“Purchase Price”) shall consist of: 
 (a) a payment in Immediately Available
Funds at the Closing in the amount of One Million Dollars ($1,000,000) (the “Closing Payment”), less the Escrow Deposit (as described in Section 1.8 below) and the Accrued PTO Adjustment (as described in
Section 1.10(b) below) (the “Adjusted Closing Payment”); 
 (b) earnout payments, if any, payable as follows
and in accordance with the provisions set forth below: 
 (i) an earnout payment (“Earnout Payment”), which
shall be payable to Seller and shall be equal to (i) six and one half (6.5) times the Profit of the Earnout Business (as defined in Exhibit B) during the Earnout Measurement Period (as defined in Exhibit B) for the first One
Million Three Hundred Fifty Thousand Dollars ($1,350,000) of the Profit of the Earnout Business, plus one (1) times the Profit of the Earnout Business for any Profit of the Earnout Business in excess of One Million Three Hundred Fifty Thousand
Dollars ($1,350,000)), minus (ii) the amount of the Closing Payment; which Earnout Payment, if any, will be paid by Acquirors in Immediately Available Funds within one hundred five (105) days of the completion of the Earnout Measurement
Period, unless the Earnout Payment is subject to the Earnout Procedures set forth in Section 1.5, in which case the time frames set forth in Section 1.5 will apply. A description of the calculation methodology for the Earnout
Payment is set forth in Exhibit B, ; and 

  
 -2- 

 (ii) a supplemental earnout payment (“Supplemental
Earnout Payment”), which shall be payable to Seller and shall be equal to (i) six and one half (6.5) times the Profit of the Earnout Business during the Supplemental Earnout Measurement Period (as defined in Exhibit B) for
the first One Million Three Hundred Fifty Thousand Dollars ($1,350,000) of the Profit of the Earnout Business, plus one (1) times the Profit of the Earnout Business for any Profit of the Earnout Business in excess of One Million Three Hundred
Fifty Thousand Dollars ($1,350,000), plus (ii) the Tuck-in Acquisition Payment (as defined in Exhibit B), minus (iii) the sum of the Closing Payment and the Earnout Payment; which Supplemental Earnout Payment, if any, will be paid
by Acquirors in Immediately Available Funds within one hundred five (105) days of the completion of the Supplemental Earnout Measurement Period, unless the Supplemental Earnout Payment is subject to the Earnout Procedures set forth in
Section 1.5, in which case the time frames set forth in Section 1.5 will apply; and 
 (c) assumption by Acquirors
on the Closing Date of the Assumed Liabilities (as defined in Section 1.11), pursuant to the terms of a Bill of Sale, Assignment and Assumption Agreement in substantially the form agreed to by Acquirors and Selling Group (the
“Bill of Sale”). 
 (d) The Closing Payment may be reduced by the amount of any payment for malpractice tail coverage for
the Transferred Providers as applicable and as contemplated in Section 5.8 that is not paid by Seller prior to or at Closing (the “Tail Withhold”). Any such Tail Withhold shall be reimbursed to Seller in Immediately
Available Funds at such time that Seller produces evidence of malpractice tail coverage and payment for such coverage according to the terms described in Section 5.8. Notwithstanding the foregoing, should Seller not produce such evidence
prior to or at Closing, Acquirors shall procure such tail coverage on behalf Seller’s Providers and shall remit the Tail Withhold to the relevant malpractice carrier or broker. 

(e) EHR-Related Payments. Any incentive payments related to the Earnout Business that are received by PC Buyer for the adoption and/or
implementation of an electronic health record (“EHR”) system or program, less the costs and expenses associated with such EHR adoption and/or implementation (regardless of how Acquirors treat such costs for accounting purposes)
shall be payable to Selling Group at the time of the Earnout Payment or Supplemental Earnout Payment, as applicable. Any such EHR incentive payments or implementation costs or expenses shall not be counted in the calculation of the Earnout Payment
or Supplemental Earnout Payment. The types of costs and expenses related to EHR implementation shall be mutually agreed upon by the parties prior to Closing. 

1.5 Earnout Procedures. 

(a) Acquirors shall provide the Seller with a statement (an “Earnout Statement”) setting forth Acquiror’s calculation of
the Earnout Payment, if any, and Supplemental Earnout Payment, if any, due Seller, within seventy five (75) days after the end of each of the Earnout Measurement Period and the Supplemental Earnout Measurement Period, as applicable, together
with reasonably detailed financial information supporting each such 

  
 -3- 

 
calculation. Acquirors agree to promptly provide Seller with any additional detailed financial information Seller requests and that is reasonably related to either the methodology by which the
Earnout Payment or the Supplemental Earnout Payment is calculated, including the methodology by which revenue is accrued, or the specific items of revenue and expense that affect each such calculation. Seller shall have the right to engage an
accounting expert, at Seller’s sole cost and expense, to advise Seller in the evaluation of the information provided by Acquirors. Continued employment by Owners with PC Buyer is not required for receipt by Seller of any Earnout Payment or
Supplemental Earnout Payment, to the extent such payments are otherwise earned and payable. After receipt of the applicable Earnout Statement, Seller shall have thirty (30) days to review the applicable Earnout Statement. If, during such thirty
(30) day period, Seller notifies Acquirors in writing of its objection to the Earnout Statement (the “Objection Notice”), Acquirors and Seller agree, within thirty (30) days (or such longer period as the parties may agree)
following such Objection Notice, to negotiate in good faith for a period of thirty (30) days in an attempt to establish a mutually acceptable Earnout Payment or Supplemental Earnout Payment, as applicable. Any resolution by Seller and Acquirors
as to any disputed Earnout Payment or Supplemental Earnout Payment shall be set forth in a writing executed by the Seller and Acquirors, and shall evidence the final, binding and conclusive resolution of the parties relating to such payment,
including the timing of such payment. 
 (b) If, at the conclusion of such thirty (30) day review period, any Earnout Payment or
Supplemental Earnout Payment, as applicable, remains in dispute, then Acquirors and Seller shall engage a mutually agreed upon independent accounting firm with no material relationship with Acquirors or Seller (the “Neutral
Auditor”) to resolve such dispute. Acquirors and Seller acknowledge and agree that, if an Earnout Payment or Supplemental Earnout Payment matter is referred to the Neutral Auditor, the matter shall be jointly submitted to the Neutral
Auditor in writing, with specific instructions that the Neutral Auditor (i) shall act as an expert in accounting, and not as an arbitrator, to resolve, in accordance with this Section 1.5 only the matters specified in writing as
being in dispute; (ii) may not determine any component of the Earnout Payment or Supplemental Earnout Payment, as applicable, in excess of that claimed by Seller or less than that claimed by Acquirors; and (iii) shall deliver to Acquirors
and Seller a written decision as promptly as practicable and in any event within seventy-five (75) days following the submission of the matter to the Neutral Auditor for resolution. The Neutral Auditor shall deliver to Acquirors and Seller, as
promptly as practicable, a report setting forth its determination(s) regarding the Earnout Payment or Supplemental Earnout Payment, as applicable. Acquirors and Seller acknowledge and agree that, if any dispute is submitted to the Neutral Auditor
pursuant to this Section 1.5, the component of the Earnout Payment or the Supplemental Earnout Payment, as applicable, determined by the Neutral Auditor shall be final, binding, and conclusive for purposes of this Agreement and within
fifteen (15) days after becoming final, binding, and conclusive, shall be paid by Acquirors to Seller, or by Seller to Acquirors, as applicable by wire transfer of Immediately Available Funds to an account designated by the receiving party.
Acquirors and Seller waive, and shall not assert, any other right or remedy with respect to such component of the Earnout Payment or Supplemental Earnout Payment, as applicable, to the extent determined in accordance with this Section 1.5(b).

 (c) Notwithstanding and in addition to the above, for up to ninety (90) days after payment of the Earnout Payment and up to six
(6) months after payment of the Supplemental Earnout Payment, Acquiror will promptly provide Seller with any additional 

  
 -4- 

 
financial information requested by Seller for the purpose of reviewing the accrual of revenue generated other than as a result of fee for service billing for medical services, including but not
limited to facility payments and incentive or outcomes based or other similar payments (the “Non Fee-For-Service Revenues”) If Seller notifies Acquiror in writing of its objection to the Earnout Statement during the ninety
(90) days after the payment of the Earnout Payment, or its objection to the Earnout Statement or the Supplemental Earnout Statement during the six (6) months after payment of the Supplemental Earnout Payment, solely as a result of an
objection to the amount of Non Fee-For-Service Revenue in either or both of the Earnout Statement or the Supplemental Earnout Statement (the “Additional Objection Notice”), Acquirors and Seller agree, within thirty (30) days
(or such longer period as the parties may agree) following such Additional Objection Notice, to negotiate in good faith for a period of thirty (30) days in an attempt to establish a mutually acceptable Earnout Payment or Supplemental Earnout
Payment, as applicable. Any resolution by Seller and Acquiror as to any disputed Earnout Payment or Supplemental Earnout Payment shall be set forth in a writing executed by the Seller and Acquiror, and shall evidence the final, binding and
conclusive resolution of the parties relating to such payment, including the timing of such payment. If, at the conclusion of such thirty (30) day review period, any Earnout Payment or Supplemental Earnout Payment, as applicable, remains in
dispute, then Acquiror and Seller shall submit the matter to a Neutral Auditor in accordance with Section 1.5(b) above and Section 1.5(d) below. For purposes of the time frames in this Section 1.5(c), if no
Earnout Payment or Supplemental Earnout Payment is made, the applicable time period will commence as of the date by which any payment would have been made if a payment was due. 

(d) In connection with any dispute relating to the Earnout Payment or Supplemental Earnout Payment, as applicable, that is referred to the
Neutral Auditor pursuant to Section 1.5, Acquirors and Seller agree as follows: 
 (i) Acquirors and Seller shall
execute any agreement(s) required by the Neutral Auditor to accept their engagement pursuant to this Section 1.5. 

(ii) The fees, costs, and expenses shall be paid by the non-prevailing party, which in this context shall be the party whose
proposed component of the Earnout Payment or Supplemental Earnout Payment, as applicable, has the greatest difference from any such amount determined by the Neutral Auditor (e.g., if Seller contends that the Earnout Payment payable to Seller
is $3,000,000, and Acquirors contend that it is $2,250,000, and the Neutral Auditor concludes that the amount payable is $2,750,000, then Acquirors would be deemed to be the non-prevailing party). Notwithstanding the foregoing, for purposes of this
subsection, if both Acquirors and Seller are within five percent (5%) of the amount determined by the Neutral Auditor, then Acquirors and Seller shall each bear and pay fifty percent (50%) of the fees and costs of the Neutral Auditor. 

(iii) Acquirors and Seller agree to engage the Neutral Auditor on a joint basis. All written communication between one party
and the Neutral Auditor shall be shared with the other party, and neither Acquirors nor Seller shall engage in verbal communications without the other party having the reasonable opportunity to participate. 

  
 -5- 

 1.6 IRS Form 8594. Acquirors and Selling Group agree that the asset allocation set forth
in their respective Internal Revenue Service Form(s) 8594 shall be consistent with the Form(s) 8594 submitted by the other parties. 
 1.7
Payment Instructions. Acquirors’ payment of the Purchase Price shall be paid in accordance with written instructions provided by the Selling Group to Acquirors (the “Payment Instructions”). The Payment Instructions shall
include, if any, the specific amounts to be paid to any third party. Seller and Owners shall indemnify and hold harmless Acquirors from any claims, liabilities or obligations, including any Tax withholdings, assessments, payments or penalties,
resulting from such Payment Instructions or any allocation or characterization by members of the Selling Group of the Purchase Price or the Purchased Assets for Tax reporting or Tax payment purposes. 

1.8 Escrow. On the Closing Date, pursuant to the escrow agreement in substantially the form agreed to by Acquirors and Selling Group
(the “Escrow Agreement”), Acquirors shall deliver to Wells Fargo Bank, National Association (the “Escrow Agent”) a wire transfer in an amount equal to the Escrow Deposit (as defined in Section 8.9),
which amount shall be deemed withheld from the Adjusted Closing Payment and shall be deposited with the Escrow Agent for the purpose of securing the indemnification obligations of Seller in Section 6.2 (a) following the Closing. The
Escrow Deposit shall be held and disbursed solely for the purposes and in accordance with the terms of the Escrow Agreement. Acquirors, on the one hand, and Seller, on the other hand, shall bear the cost of the Escrow Agent equally. 

1.9 Prorations. The parties agree to prorate between them based upon their respective periods of ownership of the Business, any office
rents, utility charges, real or personal property taxes or amounts received for services provided or to be provided under any Revenue Contracts (as defined in Section 8.9) that have been assigned to PC Buyer and other similar expenses
relating to the Purchased Assets (except any expenses which are related to the Excluded Assets) which cover both the period prior to and after the Closing to the extent such expenses are paid by one party and benefit the other party (the
“Prorations”). To the extent practicable and as applicable, the Prorations shall be based upon square footage, utility meter readings, time periods covered by the payments, and the like, as applicable. The Prorations shall be paid
promptly upon receipt of an invoice and reasonable supporting documentation from the party claiming reimbursement. 
 1.10 Assumed
Liabilities. 
 (a) Upon the terms and subject to the satisfaction of the conditions of this Agreement, and in reliance on the
representations, warranties and agreements of Seller set forth herein, at the Closing, Seller shall assign, and each of the Acquirors shall assume and agree to perform and discharge only those liabilities set forth on Schedule 1.10, except
that Buyer and PC Buyer, as applicable, shall assume: (i) the Liabilities arising prior to the Closing Date to perform services after the Closing pursuant to the Revenue Contracts that have been assigned to PC Buyer, as set forth in Schedule
1.10, and any other contracts being assumed pursuant to this Agreement, but only to the extent each of such Liabilities is incurred after the Closing; and (ii), subject to the Purchase Price adjustment described in paragraph (b) below,
Seller’s liability for unused sick days, personal days, vacation days and any other paid time off (collectively the “Accrued PTO”) with respect to the Transferred Providers, Transferred Management

  
 -6- 

 
Employees and Administrative Personnel hired by Buyer or PC Buyer but only to the extent set forth in Schedule 1.10, which Schedule shall be completed prior to the Closing, and not paid by
Seller on or prior to the Closing (together, the “Assumed Liabilities”). 
 (b) The sum of the Accrued PTO as of the
Closing (collectively the “Accrued PTO Adjustment”) shall be deducted from the Purchase Price at the Closing. 
 1.11
Excluded Liabilities. The Assumed Liabilities shall specifically exclude, and the parties agree that none of the Acquirors hereby assumes or at any time hereafter shall become liable for, any Liabilities of any kind of any member of the
Selling Group or any of their Affiliates other than the Assumed Liabilities. Such excluded liabilities include any Liabilities of any kind relating to the Business or its operation prior to the Closing, whether or not such Liabilities arise or are
asserted after the Closing (including without limitation any Liability for any medical malpractice claims against Seller, any Owner or Provider, any Liability of Seller related to the provision of items and services to beneficiaries of the Medicare,
Medicaid or other health care programs, or to billing for the provision of such items and services to any payor, or in connection with any Employee Benefit Plan (as defined in Section 8.9) or accrued but unpaid benefits (including
bonuses for Transferred Providers accrued prior to the Closing), or relating to the H1-B or J-1 visa status of any employee or contractor while under the employ of or contract with Seller, or to any current or former owner, employee or contractor of
Seller, or with respect to any Tax for any period prior to the Closing) other than the Assumed Liabilities (the “Excluded Liabilities”). 

1.12 Transfer Taxes. Each party shall be responsible for and shall each pay on the Closing, or when due, whichever is later, one-half
of all transfer taxes incurred, if any, solely by virtue of the transfer by Seller of the Purchased Assets to Acquirors as contemplated by this Agreement. Each party shall prepare, in accordance with all applicable laws, regulations or other
requirements, and each party, as appropriate, shall in a timely manner sign and swear to any return, certificate, questionnaire or affidavit properly prepared as to any matter within such party’s knowledge required in connection with the
payment of any such tax. 
 1.13 Closing. Subject to the conditions set forth in this Agreement, the purchase and sale of the
Purchased Assets pursuant to this Agreement (the “Closing”) shall take place, to the extent such Closing cannot take place through the electronic exchange of signatures, at the offices of IPC The Hospitalist Company, Inc., 4605
Lankershim Boulevard, Suite 617, North Hollywood, CA 91602 at 12:00 noon local time, within two (2) business days after the conditions set forth in ARTICLE II have been satisfied, but no later than December 16, 2013, or at such
other time, place and date as shall be mutually agreed on in writing by Acquirors and the Selling Group. The date on which the Closing occurs is identified as the “Closing Date” and the Closing shall be deemed to be effective as of
12:01 a.m. Eastern Daylight Time on the Closing Date. 
 (a) At the Closing, (i) Seller shall sell, assign, convey, transfer and
deliver to Buyer good and marketable title to all of the Acquired Assets; (B) Seller shall sell, assign, convey, transfer and deliver to PC Buyer good and marketable title to all of the PC Acquired Assets; (iii) Seller shall execute and
deliver to Acquirors (A) the Bill of Sale; and (B) the Seller Noncompetition Agreement (as defined in Section 2.1(c)) in favor of an Acquiror executed by Seller; and (iv) the Selling Group shall deliver such other
assignments, certificates and other instruments and documents as may be required to be delivered by Seller at or prior to the Closing or as may be reasonably requested by Acquirors. 

  
 -7- 

 (b) At the Closing, (i) each of the Acquirors shall accept and purchase the applicable
Purchased Assets from Seller and in consideration therefor shall (A) pay the Closing Payment in Immediately Available Funds; (B) execute and deliver the Bill of Sale; and (C) deliver to Seller all certificates and other instruments
and documents as may be required to be delivered by any of the Acquirors hereunder at or prior to the Closing or as may be reasonably requested by Seller; and (ii) PC Buyer shall execute and deliver the Seller Noncompetition Agreement to
Seller. 
 1.14 Records. After the Closing, Acquirors and their Affiliates and each of their respective authorized agents and
representatives (including accountants, consultants, counsel and other advisors) shall have access to all books, ledgers, files, records, manuals, documents and other materials and information relating to the Business as it was conducted prior to
the Closing, and the right to review, copy and audit such books, ledgers, files, records, manuals, documents and other materials and information, at Acquirors’ expense during normal business hours upon advance notice, so long as Seller
maintains such items, which shall in no event be less than six (6) years after the Closing or such longer period as Seller may be required by Law to maintain same. 

ARTICLE II 
 CONDITIONS
TO CLOSING 
 2.1 Conditions to Acquirors’ Obligations. Acquirors’ obligations to consummate the transactions
contemplated by this Agreement are subject to, unless waived in writing by Acquirors, satisfaction of the following conditions: 
 (a) a
certificate of the President of Seller, in form and substance satisfactory to Acquirors, shall be delivered to Acquirors at the Closing certifying that (i) the individual signing such certificate has the authority to bind Seller; (ii) each
of the representations and warranties of the Selling Group set forth in ARTICLE III are true and correct in all respects at and as of the Closing Date; (iii) all agreements, undertakings and obligations to be performed or complied with
by the Selling Group as of or prior to the Closing Date, unless waived in writing, have been duly performed or complied with in all respects, to the extent applicable, by each member of the Selling Group in accordance with the terms of this
Agreement; and (iv) all of the conditions set forth in Section 2.1 have been satisfied in all respects, unless waived in writing, at or prior to the Closing Date; 

(b) a certificate of the Secretary of Seller, in form and substance reasonably satisfactory to Acquirors, shall be delivered to Acquirors at
the Closing certifying that (i) attached thereto are true and correct copies of the resolutions duly and validly adopted by Seller authorizing the execution and delivery of this Agreement and its Exhibits and Schedules and the consummation of
the transactions contemplated hereby and thereby, and (ii) each shareholder of Seller, as required by Law and the organizational documents of Seller, has consented to and authorized the execution and delivery of this Agreement, its Exhibits and
Schedules, and the Seller Noncompetition Agreement and the consummation of the transactions contemplated hereby and thereby; 

  
 -8- 

 (c) Seller shall enter into a noncompetition agreement with PC Buyer, in substantially the form
of Exhibit D (“Seller Noncompetition Agreement”); 
 (d) Providers representing more than fifteen percent
(15%) of the unit volume of the Business, as reasonably determined by Acquirors, shall not have given written or oral notice of termination of their applicable employment agreement, and the remainder of the Providers (i) shall meet the
employment criteria of PC Buyer, (ii) shall have the proper H-1B or J-1 visa, as applicable, and active privileges for their current work locations and (iii) shall have been employed by PC Buyer at the Closing provided that PC Buyer takes
all reasonably necessary attempts to employ such Providers so that such Providers are employed by PC Buyer as of the Closing and will only fail to employ such Providers for “Cause” (as defined in Section 5.2 herein); 

(e) the employment agreements between Seller and the Transferred Providers shall have been assigned to PC Buyer, at or prior to the Closing,
on terms acceptable to PC Buyer; provided that in the event that any of the employment agreements between Seller and Transferred Providers cannot be assigned or contain terms that are not reasonably acceptable to PC Buyer, then each member of the
Selling Group shall use its best efforts to assist PC Buyer in obtaining new employment agreements between PC Buyer and the applicable Transferred Providers, on terms reasonably acceptable to PC Buyer; 

(f) no more than twenty percent (20%) of the administrative personnel working for Seller prior to the Closing and necessary for the
conduct of the Business post-Closing as reasonably determined by Acquirors (“Administrative Personnel”) shall have been employed by an Acquiror or an Affiliate of Acquirors at the Closing; 

(g) Seller shall have removed any and all Liens, loans and other debts, including any outstanding tax obligations, on or affecting the
Purchased Assets and delivered evidence of same to Acquirors in form and substance reasonably satisfactory to Acquirors; 
 (h) Seller shall
have provided Acquirors with copies of all Revenue Contracts and/or other health care related agreements (“Healthcare Agreements”) held by Seller, each Owner or any Provider relating to Seller’s Business and the PC Acquired
Assets, that will be assumed by PC Buyer, and each Healthcare Agreement to Selling Group’s Knowledge shall be in full compliance with all Laws or shall have been amended or terminated prior to the Closing; 

(i) Seller shall have terminated any and all agreements held by Seller related to the Purchased Assets that will not be transferred or
assigned to Acquirors, on terms acceptable to Acquirors, at the Closing; 
 (j) Seller shall have obtained all third party consents
necessary to transfer the Purchased Assets to Acquirors on terms acceptable to Acquirors, including the consents necessary to assign the Revenue Contracts, the Contracts or Real Property Leases (as defined in Section 3.14) included in
the Purchased Assets; provided that Seller shall have additional time, as set forth in Section 5.16, to obtain third party consents necessary to transfer those certain Contracts defined in Section 5.16; 

  
 -9- 

 (k) no action, suit or proceeding shall be pending or threatened before any court or
quasi-judicial or administrative agency of any federal, state, local or foreign jurisdiction or before any arbitrator wherein an unfavorable injunction, judgment, order, decree, ruling or charge would (i) prevent consummation of the
transactions contemplated by this Agreement; (ii) cause any of the transactions contemplated by this Agreement to be rescinded following consummation; or (iii) affect adversely the right of Acquirors to own the Purchased Assets and operate
the Business and no such injunction, judgment, order, decree, ruling or charge shall be in effect; 
 (l) all actions to be taken by Seller
and each Owner in connection with the consummation of the transactions contemplated hereby and all certificates, instruments and other documents required to effect the transactions contemplated hereby shall be reasonably satisfactory in form and
substance to Acquirors; 
 (m) Seller shall provide Acquirors with a copy of a certificate of existence or good standing for Seller dated
within thirty (30) business days prior to the Closing Date for each jurisdiction in which Seller conducts business; 
 (n) Seller shall
provide Acquirors with a completed certification of non foreign status pursuant to Section 1.1445 2(b)(2) of the Treasury regulations, duly executed by Seller; 

(o) Seller and each Owner shall have executed this Agreement, its Exhibits and Schedules, as applicable, and such other agreements
contemplated herein to which Seller and each Owner are a party and delivered such executed documents to Acquirors, as applicable; 
 (p)
Seller will procure or will make arrangements to procure professional malpractice tail coverage, in accordance with Section 1.4 and Section 5.8, herein and provide evidence of coverage satisfactory to Acquirors (including
providing Acquirors with a copy of a quote for malpractice tail insurance prior to Closing), for a professional malpractice tail policy to or an occurrence based policy under Seller’s malpractice insurance, covering each of the Transferred
Providers to the extent such Transferred Providers do not currently maintain an occurrence based policy, for all periods prior to the Closing, in accordance with Section 5.8 herein; 

(q) no statute, rule, regulation, ruling, consent, decree, judgment, injunction or order shall be enacted, promulgated, entered or enforced by
any court or governmental authority which would prohibit consummation by the parties hereto of the transactions contemplated hereby; 
 (r)
Seller shall have delivered to Acquirors a certificate of the President of Seller, in form and substance satisfactory to Acquirors, certifying that all obligations and covenants required by this Agreement to be performed or to be complied with by
Seller on or prior to the Closing Date shall have been duly performed or complied with in all material respects; 

  
 -10- 

 (s) Seller shall have delivered to Acquirors a certificate of the President of Seller, in form
and substance satisfactory to Acquirors, certifying that Seller shall not have suffered a Material Adverse Effect; 
 (t) Seller shall have
provided information satisfactory to Acquirors regarding all ongoing interest in or relationships with health care related businesses other than Seller and its Affiliates, and such interests or relationships shall be deemed acceptable under all
Laws, as determined in Acquirors’ sole discretion; 
 (u) Intentionally deleted; and 

(v) the closing of the transactions contemplated by (i) that certain Asset Purchase Agreement by and among Hospitalist Management
Consultants of New York, Inc., InPatient Hospitalist Services of New York, P.C., Park Avenue Health Care Management, LLC, Park Avenue Medical Associates, P.C., and the individuals listed on Exhibit A thereto, and (ii) that certain Asset
Purchase Agreement by and among IPC Management Consultants of New York, Inc., InPatient Hospitalist Healthcare Services of New York, P.C., Geriatric Services, P.C. and the individuals listed on Exhibit A thereto, which are being entered into
contemporaneously with the execution of this Agreement, shall occur simultaneously with the Closing. 
 2.2 Conditions to Seller’s
Obligations. Seller’s obligations to consummate the transactions contemplated by this Agreement are subject to, unless waived in writing by Seller, satisfaction of the following conditions: 

(a) a certificate of the President of each Acquiror, in form and substance reasonably satisfactory to Seller, shall be delivered to Seller at
the Closing certifying that (i) the individual signing such certificate has the authority to bind such Acquiror; (ii) each of the representations and warranties set forth in ARTICLE IV are true and correct at and as of the
Closing Date; (iii) all agreements, undertakings and obligations to be performed or complied with by each Acquiror as of or prior to the Closing Date, unless waived in writing, have been duly performed or complied with by each Acquiror in
accordance with the terms of this Agreement; and (iv) all of the conditions set forth in this Section 2.2 have been satisfied at or prior to the Closing Date; 

(b) a certificate of the Secretary of each Acquiror, in form and substance reasonably satisfactory to Seller, shall be delivered to Seller at
the Closing certifying that attached thereto are true and correct copies of the resolutions duly and validly adopted by each Acquiror authorizing the execution and delivery of this Agreement and its Exhibits and Schedules and the consummation of the
transactions contemplated hereby and thereby; 
 (c) Acquirors shall have delivered to Seller each of the items required to be so delivered,
and shall have made the payment required to be made to Seller, pursuant to Section 1.13(b) at or prior to the Closing Date; 

(d) each of the Acquirors shall have executed this Agreement, its Exhibits and Schedules, the Noncompetition Agreements and such other
agreements contemplated herein to which such Acquiror is a party and shall have delivered such executed documents to Seller; 

  
 -11- 

 (e) all actions to be taken by Acquirors in connection with the consummation of the transactions
contemplated hereby and all certificates, instruments and other documents required to effect the transactions contemplated hereby shall be reasonably satisfactory in form and substance to Seller; 

(f) no action, suit or proceeding shall be pending or threatened before any court or quasi-judicial or administrative agency of any federal,
state, local or foreign jurisdiction or before any arbitrator wherein an unfavorable injunction, judgment, order, decree, ruling or charge would (i) prevent consummation of the transactions contemplated by this Agreement; or (ii) cause any
of the transactions contemplated by this Agreement to be rescinded following consummation, and no such injunction, judgment, order, decree, ruling or charge shall be in effect; 

(g) no statute, rule, regulation, ruling, consent, decree, judgment, injunction or order shall be enacted, promulgated, entered or enforced by
any court or governmental authority which would prohibit consummation by the parties hereto of the transactions contemplated hereby; 
 (h)
Acquirors shall have delivered to Seller a certificate of the President of each Acquiror, in form and substance satisfactory to Seller, certifying that all obligations and covenants required by this Agreement to be performed or to be complied with
by Acquirors on or prior to the Closing Date shall have been duly performed or complied with in all material respects; and 
 (i) the
closing of the transactions contemplated by (i) that certain Asset Purchase Agreement by and among Hospitalist Management Consultants of New York, Inc., InPatient Hospitalist Services of New York, P.C., Park Avenue Health Care Management, LLC,
Park Avenue Medical Associates, P.C., and the individuals listed on Exhibit A thereto, and (ii) that certain Asset Purchase Agreement by and among IPC Management Consultants of New York, Inc., InPatient Hospitalist Healthcare Services of
New York, P.C., Geriatric Services, P.C. and the individuals listed on Exhibit A thereto, which are being entered into contemporaneously with the execution of this Agreement, shall occur simultaneously with the Closing. 

ARTICLE III 

REPRESENTATIONS AND WARRANTIES OF SELLER AND OWNERS 

In order to induce each of the Acquirors to enter into this Agreement and to purchase the Purchased Assets, each of the Seller and Owners
hereby jointly and severally represents and warrants to each of the Acquirors all of the matters set forth in this ARTICLE III; any exceptions to such representations and warranties shall be set forth in a disclosure schedule specifying
in each case to which section of ARTICLE III such exceptions apply (the “Disclosure Schedules”). 
 3.1
Organization. Seller is a limited liability company, duly organized, validly existing and in good standing under the laws of its state of formation and each state of operation, and has all requisite power and authority to own, lease and
operate its properties and to carry on its Business as now being conducted. Neither the ownership of its properties nor the operation of its Business requires Seller to be qualified in any jurisdiction other than its state of formation and each
state of operation. Owners hold all of the outstanding ownership interests of Seller in the amounts set forth on Schedule 3.1, and no other Person has any equity interest or ownership interest whether direct, indirect or derivative, in
Seller. 

  
 -12- 

 3.2 Authority Relative to this Agreement. Each member of the Selling Group has all
requisite power and authority to execute and deliver this Agreement and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement and the consummation of the transactions contemplated hereby have been duly and
validly authorized by each member of the Selling Group and, except as set forth on Schedule 3.2, no other actions on the part of any Person is necessary to authorize this Agreement or to consummate the transactions contemplated hereby. This
Agreement has been duly and validly executed and delivered by each member of the Selling Group and constitutes a valid and binding agreement of each such party, enforceable against each such party in accordance with its terms, except as such
agreement may be limited by the availability of equitable remedies, or by bankruptcy, insolvency or other Laws affecting the enforcement of creditors’ rights. 

3.3 No Violation. Neither the execution and delivery of this Agreement by any member of the Selling Group nor the consummation by any
member of the Selling Group of the transactions contemplated hereby will: (i) conflict with or result in any breach of any provision of the Articles of Incorporation, Articles of Formation, Bylaws or Operating Agreement, as applicable, or other
governing documents of such entity; (ii) to the Selling Group’s Knowledge, conflict with, result in any breach of any provision of, or constitute a default or permit any Person to terminate, accelerate the performance required by, or
accelerate the maturity of, any indebtedness or other obligation relating to any member of the Selling Group or the Purchased Assets under any contract or agreement of any kind to which any of the foregoing is a party or to which it or any of them
or any of the Purchased Assets is subject; (iii) to the Selling Group’s Knowledge, violate or conflict with any Law to which any member of the Selling Group or any of the Purchased Assets is subject; or (iv) result in the creation or
imposition of any Lien on any property of Seller (including the Acquired Assets or the PC Acquired Assets). 
 3.4 Purchased Assets.
The Purchased Assets that are tangible assets (“Tangible Assets”): (i) are in good operating condition and repair, subject to normal wear and maintenance; (ii) to Selling Group’s Knowledge, meet all applicable
governmental standards and conform to all applicable Laws relating to their construction, use and operation; and (iii) are useable in the regular and ordinary course of business as operated by Seller. Seller owns and has good and marketable
title to all of the Tangible Assets. All Purchased Assets (including all leasehold interests included in the Purchased Assets) are owned by Seller free and clear of any Lien. Upon consummation of the transactions contemplated by this Agreement,
Acquirors will acquire good and marketable title to the Purchased Assets, including the Tangible Assets, free and clear of all Liens, except for Liens imposed by statute securing the payment of Taxes which are not due as of the Closing Date and are
listed in Schedule 3.4. 
 3.5 Intellectual Property. Schedule 3.5 lists all of the Intellectual Property of Seller
used or held for use in the Business except for commercially available software utilized in the ordinary course of business functions (“Routine Software”). Any such Intellectual Property other than Routine Software used by Seller or
which Seller has given others the right to use pursuant to a license, sublicense or agreement is specifically identified in Schedule 3.5, and Seller has delivered complete and accurate copies of each such license, sublicense or agreement to
Acquirors. The other Intellectual Property owned by Seller is free and clear of all Liens. To 

  
 -13- 

 
the Selling Group’s Knowledge, the use of Intellectual Property in the Business does not infringe the intellectual property rights of any Person under any Laws, and no claims have been made
by any Person that Seller does not own or have the right to use any Intellectual Property or that the use of any Intellectual Property by Seller in the conduct and operation of the Business infringes the intellectual property rights of any third
party. Except as set forth in Schedule 3.5, Seller has not authorized the use of its Intellectual Property by any third party. Seller is not in default and, to Selling Group’s Knowledge, no third party is in default, under any license,
sublicense or agreement by which it holds, or has given to others the right to use, any Intellectual Property. 
 3.6
Employees/Contractors. An accurate and complete list of all employees and independent contractors of Seller (including candidates with extended offers) and related information is set forth in Schedule 3.6, including current annual
salary or hourly rate of pay, title, position, classification, bonus paid in 2012 and 2013, accrued vacation or paid time off, amount of any severance payable to such employee, if any, in the event of such employee’s termination without cause,
date of hire, current status as either active or on leave, and location of employment. Except as listed in Schedule 3.6, all of Seller’s employed or contracted Providers have active privileges for their current work location and the
proper H1-B or J-1 visas, as applicable. Seller has not made any written or oral promise to any employee or independent contractor regarding a guarantee of employment with any Acquiror, any increase in his or her annual fees, compensation, benefits
or any severance or similar payments in connection with such employee’s, independent contractor’s or candidate’s employment or engagement or continued employment or engagement with any Acquiror. Except as listed in Schedule
3.6, no employee, independent contractor or candidate of Seller terminated through the Closing Date is entitled to any severance payments, termination allowance or similar payments as a result of such termination that will continue beyond the
Closing Date. Owners and all Providers employed by or contracted with Seller who will be employed by PC Buyer as of the Closing Date meet the following criteria: 

(a) For all Providers, except as listed in Schedule 3.6, (i) to Selling Group’s Knowledge, each Provider (A) is actively
enrolled in the Medicare and Medicaid programs and all Medicare and Medicaid billings for such Provider have been properly submitted under the Provider’s UPIN number(s) with Seller; (B) is not currently excluded, debarred or otherwise
ineligible to participate in federal health care programs (as defined at 42 U.S.C. § 1320a-7b(f)), (C) has never been convicted of a criminal offense related to the provision of health care items or services but has not yet been
excluded, debarred or otherwise declared ineligible to participate in federal health care programs; and (ii) to Selling Group’s Knowledge, there are no circumstances which may result in the exclusion of Seller or any Provider from
participation in any federal health care program; 
 (b) For each Provider who is a nurse practitioner, such nurse practitioner, to Selling
Group’s Knowledge, (i) is in compliance with all applicable Laws related to nursing practice, including those promulgated by the Connecticut Board of Examiners for Nursing, the Massachusetts Board of Registration in Nursing, and/or the
Vermont State Board of Nursing, as applicable, and all other applicable state authorities; and (ii) in compliance with the Medicare regulations, is certified as a nurse practitioner by a national certifying body that is recognized as such by
the Medicare program; and 

  
 -14- 

 3.7 ERISA; Benefit Plans. 

(a) Schedule 3.7(a) of the Disclosure Schedules contains a complete and accurate list of all Employee Benefit Plans of Seller, both
active and terminated. 
 (b) Each Employee Benefit Plan (and each related trust, insurance contract or fund) has been maintained, funded
and administered in compliance in all material respects with the terms of such plan and the applicable requirements of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), the Internal Revenue Code, as amended
(the “Code”), and other applicable Laws. 
 (c) All required reports and descriptions (including Form 5500 annual reports,
summary annual reports and summary plan descriptions, as applicable) have been timely filed or distributed with respect to each Employee Benefit Plan in accordance with the requirements of the Code, ERISA and applicable Law. 

(d) With respect to each Employee Benefit Plan, all required or recommended (in accordance with past practices) contributions, and payments
(including all employer contributions and employee salary reduction contributions) that are due have been paid and all contributions for any period ending on or before the Closing Date that are not yet due have been paid or have been accrued in
accordance with the past custom and practice of Seller. All premiums or other payments for all periods ending on or before the Closing Date have been paid with respect to each Employee Benefit Plan. 

(e) Each Employee Benefit Plan that is intended to meet the requirements of a “qualified plan” under Code § 401(a) has
received a favorable determination letter from the Internal Revenue Service to the effect that such Employee Benefit Plan is so qualified, and nothing has occurred since the date of such determination that could adversely affect the qualification of
such Employee Benefit Plan. 
 (f) Seller has delivered to Acquirors correct and complete copies of the plan documents and summary plan
descriptions, the most recent determination letter received from the Internal Revenue Service, the three (3) most recent Form 5500 annual reports as filed, and all related trust agreements, insurance contracts and other funding agreements that
implement each Employee Benefit Plan. 
 (g) Neither Seller nor any ERISA Affiliate (as defined in ERISA) maintains, sponsors, contributes
to or has any Liability or potential Liability with respect to any employee benefit plan that is subject to ERISA §302 or Code §412 or any Multiemployer Plan (as defined in ERISA §3(37), or otherwise has any Liability or potential
Liability under Title IV of ERISA. Seller does not have any Liability or potential Liability under ERISA or the Code solely by reason of being treated as a single employer under Code §414 with any trade, business or entity other than
Seller. 
 (h) Seller has no Liability or potential Liability with respect to any Employee Welfare Benefit Plan (as defined in ERISA
§3(1)) providing medical, health or life insurance or other welfare-type benefits for any individual (other than in accordance with COBRA). Seller and each ERISA Affiliate are in compliance in all material respects with the requirements of
COBRA. 

  
 -15- 

 (i) There have been no Prohibited Transactions (as defined under ERISA § 406 and Code
§ 4975) with respect to any Employee Benefit Plan, and no Fiduciary (as defined in ERISA §3(21)) has any Liability for breach of fiduciary duty or any other failure to act or comply in connection with the administration or investment
of the assets of any Employee Benefit Plan. No action, suit, proceeding, hearing, audit or investigation with respect to the administration or the investment of the assets of any Employee Benefit Plan (other than routine claims for benefits) is
pending or, to the Seller Group’s Knowledge, threatened. To the Seller Group’s Knowledge, there is no basis for any such action, suit, proceeding, hearing or investigation. 

(j) Seller has never been party to any arrangement that is or was a “nonqualified deferred compensation plan” within the meaning of
Code § 409A. Any Employee Benefit Plan that is deemed to constitute a nonqualified deferred compensation plan subject to Code § 409A has been operated between January 1, 2005 and December 31, 2008 in good faith compliance with
Code § 409A and the applicable notices and proposed regulations thereunder and since January 1, 2009 has been operated in accordance with, and is in documentary compliance with, the final regulations under Code § 409A. Seller does not
have any obligation to indemnify, hold harmless or gross-up any individual with respect to any penalty tax or interest under Code § 409A. 

(k) Schedule 3.7(k) lists all Persons who perform services for Seller and are designated by Seller as “independent
contractors.” Except as set forth on Schedule 3.7(k), all Persons classified by Seller as independent contractors satisfy and have at all times satisfied the requirements of applicable law to be so classified, Seller has fully and
accurately reported their compensation on IRS Forms 1099 when required to do so, and Seller does not have any obligations to provide benefits with respect to such persons under any Employee Benefit Plan or otherwise. 

(l) Neither the execution and delivery of this Agreement or other related agreements, nor the consummation of the transactions contemplated
hereby or thereby will (either alone or in conjunction with any other event, such as termination of employment) (i) result in any payment (including, without limitation, severance, unemployment compensation, parachute or otherwise) becoming due
to any current or former director, officer or employee of Seller under any Employer Benefit Plan or otherwise; (ii) significantly increase any benefits otherwise payable under any Employer Benefit Plan; or (iii) result in any acceleration
of the time of payment or vesting of any benefits. 
 3.8 Contracts and Arrangements. Schedule 3.8 sets forth all of the
contracts to which any member of the Selling Group is a party relating to the Business or the Purchased Assets. Except as set forth on Schedule 3.8, there are no oral agreements to which any member of the Selling Group is a party relating to
the Business or the Purchased Assets. Complete and accurate copies of all written contracts and related amendments to which any member of the Selling Group is a party relating to the Business or the Purchased Assets have been provided to Acquirors
prior to the Closing. Such contracts include: 
 (a) employment and/or independent contractor agreements with each employee, independent
contractor and/or candidate of Seller; 

  
 -16- 

 (b) any agreement under which Seller receives, or is entitled to receive in the future, a payment
from the other party to the agreement; 
 (c) any agreements with third party payors; 

(d) any agreement (or group of related agreements), either oral or written, under which Seller has created, incurred, assumed or guaranteed
any indebtedness for borrowed money, or any capitalized lease obligation, or any arrangement under which any member of the Selling Group or a third party has imposed a Lien on any of the Purchased Assets; 

(e) any agreement or arrangement, whether oral or written, under which Seller has loaned money to any Person or borrowed money from any
Person; 
 (f) any equipment, space or premise leases; 

(g) any agreement concerning confidentiality or noncompetition or providing for any sort of post-termination payment; 

(h) any agreement, whether oral or written, under which Seller has advanced or loaned any amount to any of its directors, officers, employees,
members, independent contractors, shareholders or Owners, or borrowed any amount from any of its directors, officers, employees, members, independent contractors or Affiliates; 

(i) any agreement which is proposed to be transferred pursuant to this Agreement and will require consent to assign by any third party; 

(j) any agreement with any Affiliate of any individual or entity in the Selling Group; 

(k) any agreement related to Intellectual Property of any individual or entity in the Selling Group; 

(l) any Healthcare Agreements or other agreements with healthcare entities; 

(m) any profit sharing, stock option, stock purchase, stock appreciation, phantom stock, deferred compensation, severance or other plan or
arrangement for the benefit of Seller’s current or former directors, officers, employees, members, independent contractors or Owners; and 

(n) any agreement of Seller that is necessary or useful for the effective and efficient operation of the Business and the Purchased Assets.

 Except as provided in Schedule 3.8, with respect to each such agreement: (x) the agreement, with respect to each member of the Selling Group,
is legal, valid, binding, enforceable, free and clear of any Lien, and in full force and effect on identical terms as set forth in the copies provided to Acquirors, following the consummation of the transactions contemplated hereby; (y) no
member of the Selling Group nor, to the Selling Group’s Knowledge, the other party(ies) thereto, is in breach or default, and no event has occurred, or will occur as a result of the transactions contemplated hereby, which with notice or lapse
of time would constitute a breach or default, or 

  
 -17- 

 
permit termination, modification or acceleration, under the agreement; and (z) no member of the Selling Group, nor, to the Selling Group’s Knowledge, the other party(ies) thereto, have
repudiated any provision of the agreement. 
 3.9 Legal Proceedings, Etc. Except as provided in Schedule 3.9 of the Disclosure
Schedule, there is no claim, suit, action, proceeding, arbitration, mediation or other dispute pending or, to Selling Group’s Knowledge, threatened affecting the Business of Seller or against any member of the Selling Group or affecting any of
the Purchased Assets, or which could reasonably be expected to affect the enforceability of any provisions in this Agreement before any court, governmental or regulatory authority or body, or any arbitral body. Neither any member of the Selling
Group nor the Purchased Assets is subject to any outstanding order, investigation, writ, injunction or decree affecting the Business of Seller or any of the Purchased Assets. 

3.10 Compliance with Laws. Except as set forth in Schedule 3.10, each of the individuals and entities in the Selling Group
is, and has conducted the Business of Seller, in compliance with all applicable Laws, including all applicable Laws respecting Medicare and Medicaid, 42 U.S.C. § 1320a-7b(b) (the “Anti-Kickback Statute”), 42 U.S.C.
§ 1395nn (the “Stark Law”), 42 U.S.C. § 1320a-7a(a)(5) (the “Beneficiary Inducement Law”); the Health Insurance Portability and Accountability Act as amended by the Health Information Technology for
Economic and Clinical Health (“HITECH Act”) and the privacy and security standards set forth at 45 C.F.R. Parts 160 and 164 (collectively “HIPAA”), employment (including the appropriate classification of employees
and independent contractors), employment practices, terms and conditions of employment and wages and hours (including severance and termination), civil rights, Taxes and filing requirements of any kind, and no member of the Selling Group has
received any notice of noncompliance with or violation of any applicable Law. No member of the Selling Group is (nor is aware that it is) currently under investigation by any governmental agency or organization (or any entity with legal authority to
conduct an investigation on behalf of same) regarding compliance with the statutes and regulations governing the provision of items and services to beneficiaries of any federal or state healthcare program, or by any commercial third-party payor in
connection with the provision of healthcare items and services to patients who are covered by such third-party payor. 

3.11 Licenses and Permits. Schedule 3.11 of the Disclosure Schedule lists all material governmental or other
permits, licenses, approvals, certificates of inspection, filings, franchises and other authorizations that are issued to, held or used by Seller, or for which Seller has applied, in connection with the current operation of the Business, and any
limitations thereto. Seller has all material governmental or other permits, licenses, approvals, certificates of inspection, filings, franchises and other authorizations that are necessary to own and operate the Purchased Assets and to conduct its
Business as it is presently being conducted and Seller has not received notice alleging that any other governmental or other permits, licenses, approvals, certificates of inspection, filings, franchises and other authorizations are required. Each
member of the Selling Group owns and will transfer to Acquirors at the Closing all licenses and permits to the extent transferable required for Acquirors’ lawful use of the Purchased Assets, except to the extent that the transfer of any license
and permit violates any Law or the terms of such license or permit and which are identified in Schedule 3.11. Seller shall reasonably cooperate with Acquirors to facilitate Acquirors’ obtaining all necessary permits and licenses in
connection with the operation of the Business effective as of the Closing Date. 

  
 -18- 

 3.12 Taxes. Except as set forth in Schedule 3.12: 

(a) Each member of the Selling Group has filed (or had filed on their behalf) all Tax Returns that they were required to file under applicable
laws and regulations. All such Tax Returns were correct and complete in all respects and were prepared in compliance with all applicable laws and regulations. All Taxes due and owing by (or with respect to the operations of) any member of the
Selling Group (whether or not shown on any Tax Return) have been paid. Adequate amounts for unpaid Taxes of any member of the Selling Group have been reserved and set aside for payment of such Taxes. No member of the Selling Group is the beneficiary
of any extension of time within which to file any Tax Return. No claim has ever been made by an authority in a jurisdiction where any member of the Selling Group did not file Tax Returns that any member of the Selling Group is or may be subject to
taxation by that jurisdiction. There are no Liens for Taxes (other than Taxes not yet due and payable) upon any of Purchased Assets. 
 (b)
Seller has withheld and paid all Taxes required to have been withheld and paid in connection with any amounts paid or owing to any employee, independent contractor, creditor, shareholder, member or other third party. 

(c) To Selling Group’s Knowledge, no foreign, federal, state or local Tax audits or administrative or judicial Tax proceedings are
pending or being conducted with respect to any member of the Selling Group or any consolidated, combined or unitary group of which Seller is or was a member. Neither Seller nor any consolidated, combined or unitary group of which it was a member has
received from any foreign, federal, state or local taxing authority (including jurisdictions where Seller or any consolidated, combined or unitary group of which it is a member has not filed Tax Returns) any (i) notice indicating an intent to
open an audit or other review; (ii) request for information related to Tax matters; or (iii) notice of deficiency or proposed adjustment for any amount of Tax proposed, asserted or assessed by any taxing authority against Seller or any
consolidated, combined or unitary group of which it is a member. 
 (d) Neither Seller nor any consolidated, combined or unitary group of
which Seller is a member has waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency. 

(e) Seller is not a party to any agreement, contract, arrangement or plan that has resulted or could result, separately or in the aggregate,
in the payment of any “excess parachute payment” within the meaning of Code § 280G (or any corresponding provision of state, local or foreign Tax law). Seller has not been a United States real property holding corporation within
the meaning of Code § 897(c)(2) during the applicable period specified in Code § 897(c)(1)(A)(ii). Seller and any consolidated, combined or unitary group of which it is a member has disclosed on its federal income Tax
Returns all positions taken therein that could give rise to a substantial understatement of federal income Tax within the meaning of Code § 6662. Seller is not a party to or bound by any Tax allocation or sharing agreement. Seller has not
been a member of an Affiliated Group (as defined in the Code) filing a consolidated federal income Tax Return and Seller does not have any Liability for the Taxes of any other Person, whether as a result of being a member of an Affiliated Group, a
transferee, successor, by contract, or otherwise. 

  
 -19- 

 (f) Seller will not be required to include any item of income in, or exclude any item of
deduction from, taxable income for any taxable period (or portion thereof) ending after the Closing Date as a result of any: 

(i) change in method of accounting for a taxable period ending on or prior to the Closing Date; 

(ii) “closing agreement” as described in Code § 7121 (or any corresponding or similar provision of state,
local or foreign income Tax law) executed on or prior to the Closing Date; 
 (iii) intercompany transaction or excess loss
account described in Treasury Regulations under Code § 1502 (or any corresponding or similar provision of state, local or foreign income Tax law); 

(iv) installment sale or open transaction disposition made on or prior to the Closing Date; or 

(v) prepaid amount received on or prior to the Closing Date. 

(g) Seller has not distributed stock of another Person or has had its stock distributed by another Person in a transaction that was purported
or intended to be governed in whole or in part by Code § 355 or Code § 361. 
 (h) Neither Seller nor any consolidated,
combined or unitary group of which Seller is a member has engaged in any “listed transaction” as defined in the Treasury Regulations promulgated under Section 6011 of the Code. 

3.13 Financial Information. Seller’s financial information provided by the Selling Group to Acquirors is true, accurate, complete
and consistent with past practices of the each member of the Selling Group, consistently applied. In 2012, Seller’s Business generated approximately Six Million Two Hundred Seventy Two Thousand Nine Hundred Twenty One Dollars ($6,272,921) in
annualized revenues (excluding any electronic health record incentive payments) and approximately Ninety Seven Thousand Four Hundred Forty Five (97,445) annualized patient encounters. 

3.14 Leased Real Property. The only real estate used in the operation of the Business (other than access to Facilities free of charge
to perform clinical services) are the real properties listed in Schedule 3.14 hereto, which are collectively referred to herein as the “Leased Real Property.” All of such Leased Real Property is leased by Seller pursuant to
contracts described in Schedule 3.14 hereto, a true and correct copy of each having been previously delivered to Acquirors (the parties from whom the Leased Real Property is leased are referred to herein as the “Landlords”),
and which have not been amended, modified or assigned (the “Real Property Leases”). With respect to the Leased Real Property: 

  
 -20- 

 (a) To Selling Group’s Knowledge, the buildings, plants, improvements, structures and
fixtures on the Leased Real Property: (i) have been properly maintained; (ii) are in good operating condition and repair, normal wear and tear excepted; (iii) are in accordance with all applicable Laws applicable to Seller or the
Leased Real Property, provided that any such noncompliance would not have a Material Adverse Effect; and (iv) while in Seller’s possession, the Leased Real Property has not been subject to any flooding, water damage or seepage; 

(b) except as set forth on Schedule 3.14 hereto, there are no leases, subleases, licenses, concessions or other agreements (whether
written or oral) to which Seller is a party, that grant to any person the right to use or occupy any portion of the Leased Real Property; 

(c) except as set forth on Schedule 3.14 hereto, there are no Persons (other than Seller) in possession of the Leased Real Property;

 (d) the Leased Real Property is supplied with utilities and other services necessary for the conduct of the Business of Seller and the
operation of the Facilities; and 
 (e) the Real Property Leases are being fully performed and are in full force and effect and are
enforceable in accordance with their terms and, to the Selling Group’s Knowledge, the Landlords are not in breach or default, or alleged to be in breach or default with respect thereto, and no conditions exist or events have occurred which with
the giving of notice or the passage of time or both could give rise to a breach or default thereunder by Seller. 
 3.15
Environmental. 
 (a) To Selling Group’s Knowledge, Seller has complied and is currently in compliance with all Environmental
Laws, and Seller possesses all environmental licenses and permits necessary to operate the Business in compliance with Environmental Law (“Licenses”) and has filed all notices or applications required by such Licenses. 

(b) Seller has not been subject to, or received any written notice of, any private, administrative or judicial action, or notice of any
intended private, administrative or judicial action relating to the presence or alleged presence of hazardous materials in, under or upon any real property currently or formerly owned, leased or used by (i) Seller or any of its predecessors; or
(ii) any Person that has, at any time, transported, treated or disposed of hazardous materials on behalf of Seller or any of its predecessors; and (iii) there are no pending or, to the Selling Group’s Knowledge, threatened actions or
proceedings (or notices of potential actions or proceedings) from any governmental authority or any other person regarding any matter relating to any Environmental Law. 

(c) To the Selling Group’s Knowledge, there are no present and have been no past events, conditions, circumstances, activities,
practices, incidents or actions that might be expected to interfere with or prevent continued compliance with any Environmental Law, give rise to any legal obligation or liability or otherwise form the basis of any claim, action, suit, proceeding,
hearing or investigation against or involving Seller or any real property presently or previously owned or used by Seller or any of its predecessors or any off-site disposal or treatment site used by Seller or any of its predecessors under any
Environmental Law or related common law theories. 

  
 -21- 

 3.16 Broker Fees. There are no broker’s or finder’s fees or obligations due to
any persons engaged by any member of the Selling Group or any of their Affiliates, employees, contractors, representatives or agents, in connection with the transactions contemplated by this Agreement except which shall be borne by Seller and paid
at the Closing. 
 3.17 Interim Conduct of Business. Since June 19, 2013, through the date hereof, Seller and each Owner have
caused the operations of Seller to be carried on in the normal course of business, diligently and lawfully, and in substantially the same manner as they previously were carried out. Since June 19, 2013, Seller has not suffered the existence or
allowed the creation of any Liens of any nature on such Seller’s property or assets, except in the ordinary course of business or as set forth in Schedule 3.17. Seller has not (a) engaged in any activities or transactions which are
outside the ordinary course of business of Seller as conducted prior to and as of June 19, 2013, which would result in a Material Adverse Effect to the Business; or (b) altered or taken any action to alter, Seller’s relationships with
its suppliers, employees, independent contractors or any other relationships related to the Business, or, its Facilities, patients, referral sources or third party payors which would result in a Material Adverse Effect to the Business. 

3.18 Undisclosed Material Liabilities. As of the date of this Agreement, there are no Liabilities of Seller of a nature required to be
reflected on a balance sheet prepared in accordance with cash basis accounting other than liabilities reflected in the Financial Statements, or which would not have a Material Adverse Effect. 

3.19 Certain Payments 

(a) Except as set forth in Schedule 3.19, and with respect to the conduct and operation of the Business of Seller, no member of the
Selling Group nor, to the Selling Group’s Knowledge, any partner, manager, officer, agent or employee of Seller or any other person associated with or acting for or on behalf of Seller, has directly or indirectly (i) made any contribution,
gift, bribe, rebate, payoff, influence payment, kickback or other payment to any person, private or public, regardless of form, whether in money, property or services (A) to obtain favorable treatment in securing business; (B) to pay for
favorable treatment for business secured; (C) to obtain special concessions or for special concessions already obtained for or with respect to Seller; or (D) which is in violation of any legal requirements; (ii) established or
maintained any fund or asset that has not been recorded in the books and records of Seller; or (iii) been a party to, or the beneficiary of, any agreement, contract, understanding or business venture (whether oral or in writing) with any person
or entity which violates the Anti-Kickback Statute or the Stark Law, any other state, federal or local law governing the referral of patients, any regulation promulgated pursuant to any of the foregoing, or any court or administrative order to any
of the foregoing. 
 (b) Except as set forth in Schedule 3.19, (i) all claims submitted by Seller for reimbursement to
third party payors (including, but not limited to, governmental payors) are true, complete and accurate; (ii) no claims for recoupment of any moneys paid to Seller have been asserted or are outstanding from third party payors, which would have
a Material Adverse Effect on the Business; (iii) the billing practices of Seller are in compliance with all applicable Laws and consistent with industry standards; (iv) no billing audits or audits by Recovery Audit Contractors, Program
Integrity Contractors or Zone Program Integrity Contractors have occurred 

  
 -22- 

 
within three (3) years prior to the date hereof nor are any such audits currently ongoing, noticed to Seller or, to the Selling Group’s Knowledge, threatened, which would have a
Material Adverse Effect on the Business; (v) no inquiries or complaints regarding quality of medical services rendered by Seller have been received by Seller which would have a Material Adverse Effect on the Business; and (vi) all
overpayments have been timely repaid by Seller in accordance with Section 1128J(d) of the Social Security Act and other applicable Law. 

3.20 Designated Health Services. If Seller has provided any “designated health services” as such term is defined in the Stark
Law, Seller has at all times operated as a “group practice” as defined in 42 C.F.R. § 411.352 and has provided such designated health services in accordance with the “in-office ancillary services” exception set forth at
42 C.F.R. § 411.352, or other applicable provisions of the Stark Law. 
 3.21 Medical Director Agreements. All Contracts of
Seller for medical director services (or other similar administrative services), and all other Contracts with any provider or supplier of healthcare items, supplies or services (each a “Health Care Entity”) have been performed in
accordance with the requirements of the Stark Law, the Anti-Kickback Statute and other applicable Laws, and no Owner or, to Selling Group’s Knowledge, Provider employee of Seller, acting within the course or scope of his or her employment, or
any member of the Selling Group has been a party to a direct or indirect financial relationship or has offered, paid, solicited or received, directly or indirectly, any remuneration from a Health Care Entity except in strict compliance with
applicable requirements of the Stark Law and the Anti-Kickback Statute. 
 3.22 Not Misleading. To Selling Group’s Knowledge,
the representations and warranties contained in this ARTICLE III do not contain any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements and information contained in ARTICLE
III not misleading. 
 ARTICLE IV 

REPRESENTATIONS AND WARRANTIES OF ACQUIRORS 

In order to induce the Selling Group to enter into this Agreement and to sell the Purchased Assets, each of the Acquirors represents and
warrants to the Selling Group all of the matters set forth in this ARTICLE IV; any exceptions to such representations and warranties shall be set forth in a Disclosure Schedules specifying in each case to which section of ARTICLE
IV such exceptions apply. 
 4.1 Organization of Acquirors. Buyer is a corporation duly organized, validly existing and in good
standing under the Laws of its state of formation and states of operation and has all requisite power and authority to own, lease and operate its properties and to carry on its business as now being conducted. PC Buyer is a professional medical
corporation duly organized, validly existing and in good standing under the Laws of its state of formation and states of operation and has all requisite power and authority to own, lease and operate its properties and to carry on its business as now
being conducted. 
 4.2 Authority Relative to this Agreement. Each of the Acquirors has all requisite power and authority to execute
and deliver this Agreement and to consummate the transactions contemplated hereby. The execution and delivery of this Agreement and the consummation of 

  
 -23- 

 
the transactions contemplated hereby have been duly and validly authorized by each Acquiror, and no other proceedings on the part of Acquirors are necessary to authorize this Agreement or to
consummate the transactions contemplated hereby. This Agreement has been duly and validly executed and delivered by Acquirors and constitutes a valid and binding agreement of each Acquiror, enforceable against Acquirors in accordance with its terms,
except as such agreement may be limited by the availability of equitable remedies or by bankruptcy, insolvency or other Laws affecting the enforcement of creditors’ rights. 

4.3 No Violation. Neither the execution and delivery of this Agreement by Acquirors nor the consummation of the transactions
contemplated hereby will (i) conflict with or result in any breach of any provision of the Articles of Incorporation, Bylaws or other similar governing documents of Acquirors; (ii) to Acquirors’ Knowledge, conflict with, result in any
material breach of any provision of, or constitute a default or permit any Person to terminate, accelerate the performance required by, or accelerate the maturity of, any indebtedness or other obligation relating to any of Acquirors under any
contract or agreement of any kind to which any of the foregoing is a party or to which any Acquiror is subject; or (iii) to Acquirors’ Knowledge, violate or conflict with any Law to which any Acquiror or any of its properties is subject.

 4.4 Legal Proceedings, Etc. There is no claim, suit, action, proceeding, arbitration, mediation or other dispute pending or, to
Acquirors’ Knowledge, threatened, which could reasonably be expected to affect the enforceability of any provision in this Agreement before any court, governmental authority or any arbitral body. 

4.5 Broker Fees. The Selling Group shall not be responsible for any broker’s or finder’s fees or obligations due to any
persons engaged by Acquirors, or any of their affiliates, employees, representatives or agents in connection with the transactions contemplated by this Agreement. 

ARTICLE V  

COVENANTS OF THE PARTIES 

5.1 Further Assurances. Subject to the terms and conditions of this Agreement, each of the parties agrees to use its commercially
reasonable efforts at its own expense (unless otherwise provided in this Agreement) to take, or cause to be taken, all action and to do, or cause to be done, all things reasonably necessary, proper or advisable under applicable Laws to consummate
and make effective the transactions contemplated by this Agreement. For at least six (6) months following the Closing, Seller and each Owner shall, during normal business hours, cooperate with Acquirors and assist Acquirors as reasonably
requested by Acquirors in the transition of the Business to Acquirors on an as-needed basis, including answering questions, facilitating the employment of those of Seller’s employees and/or independent contractors which Acquirors choose to
employ subsequent to Closing, facilitating prompt collections of its accounts receivable, introducing Acquirors to the medical community and Seller’s suppliers and service providers, and such other actions as Acquirors may reasonably request.
For at least six (6) months following the Closing, if further action is necessary or desirable to carry out the purposes of this Agreement, each of the parties, as applicable, shall take all commercially reasonable action as may reasonably be
requested by the other party. 

  
 -24- 

 5.2 Employment. 

(a) At or prior to the Closing, Seller shall serve notice of assignment of employment agreement (provided that the terms of such employment
agreements and assignments are reasonably acceptable to Buyer and/or PC Buyer) to Buyer or PC Buyer, as applicable, to its Providers, employees and/or independent contractors who will work for Buyer, PC Buyer or their Affiliate after the Closing,
and a notice of termination to its employees and/or independent contractors who will not work for Buyer, PC Buyer or their Affiliate after the Closing, and Seller shall be responsible for any obligations or payments to such Providers, employers
and/or independent contractors related to or arising from their employment or service prior to the Closing. 
 (b) At or prior to the
Closing, Seller and each Owner shall use their best efforts to assist Buyer, PC Buyer, or an Affiliate of an Acquiror, as applicable, in entering into new employment agreements with certain of Seller’s Providers, employees and/or independent
contractors who will work for Buyer, PC Buyer, or an Affiliate of an Acquiror after the Closing, and Seller shall be responsible for any obligation or payments to such Providers, employees and/or independent contractors related to or arising from
their employment or service prior to the Closing. 
 (c) PC Buyer shall not refuse without Cause to accept the assignment of an employment
agreement or enter into an employment agreement with any of Seller’s Providers who are willing to accept employment by PC Buyer on terms acceptable to PC Buyer. For purposes of this Section 5.2 and Section 2.1(e),
“Cause” shall be defined as the following: 
 (i) The Provider has failed to meet all the requirements of
any applicable state authority (e.g., state agency, professional board) to the extent applicable and required under Section 3.6, as applicable; 

(ii) The Provider has a restricted license to practice his/her profession, or has been sanctioned or placed on probation by any
applicable state authority; 
 (iii) The Provider has been sanctioned by or is in a Corrective Action Plan with Medicare,
Medicaid, or any other governmental healthcare program; 
 (iv) The Provider is currently indicted or has been convicted of,
or pleaded guilty or no contest to, a felony or crime involving moral turpitude; 
 (v) Any substantiated reason or cause
which adversely affects the ability of the Provider to perform service on behalf of PC Buyer to a substantial degree, including without limitation, alcohol, drug or substance abuse, conduct endangering the health or safety of patients, or mental
incompetence or deficiency; 
 (vi) For nurse practitioner Providers, the Provider is not actively certified through a
recognized national board; or 
 (vii) The Provider has failed to meet the [routine screening], verification of work
history, or criminal background check requirements of PC Buyer’s pre-employment risk review process. 

  
 -25- 

 (d) Acquirors agree that effective upon the Closing, (i) PC Buyer shall accept assignment,
on terms acceptable to PC Buyer, of the employment agreements or make commercially reasonably efforts to enter into new employment agreements, as applicable, with Seller’s employed or contracted Providers meeting the employment criteria of PC
Buyer in accordance with this Agreement (so that no lapse shall occur between the Closing Date and the effective date of the contract with PC Buyer) (the “Transferred Providers”) and (ii) Buyer shall accept assignment, on terms
acceptable to Buyer, of the employment agreements with Seller’s employed or contracted employees meeting the employment criteria of Buyer in accordance with this Agreement (so that no lapse shall occur between the Closing Date and the effective
date of the contract with Buyer) (the “Transferred Management Employees”). Effective as of the first day of the month following the Closing, Acquirors shall establish or make available, through itself or an Affiliate, to all of the
Transferred Providers and Transferred Management Employees, employee benefit plans (collectively “Acquirors’ Employee Plans”), in accordance with and subject to such Acquirors’ Employee Plans and the policies and
procedures of Acquirors or their Affiliates. For purposes of eligibility to participate and vesting in the Acquirors’ Employee Plans provided by Acquirors to such Transferred Providers and Transferred Management Employees (other than
Acquirors’ Employee Stock Purchase Plan), but not benefit accrual, Acquirors shall provide that the Transferred Providers and Transferred Management Employees will be credited with their years of service with Seller and any predecessors
thereof. Subject to the terms of the relevant Employee Benefit Plan, the eligibility of any Transferred Providers and Transferred Management Employees to participate in any welfare benefit plan or program of Acquirors or their Affiliates shall not
be subject to any exclusions for any pre-existing conditions or length of hire restrictions if such individual has met the participation requirements of similar benefit plans and programs of Seller. In addition, an Acquiror or an Affiliate of
Acquirors shall enter into employment relationships with Administrative Personnel whom Acquirors deem necessary to operate the Business post-Closing and who meet the employment criteria of Acquirors. 

(e) Seller shall be liable for all employee or contractor accrued compensation or bonus payments, payments that may be required to be made
under any termination, severance or similar plan, policy, arrangement or Employee Benefit Plans of Seller, or the termination of the employment of any officer or employee or independent contractor of Seller, as a result of the transactions
contemplated herein. Seller shall be responsible for the payment of any Provider stay-related, transition, or signing bonuses, severance payments, or bonus guarantees in excess of the Provider’s current salary with Seller, or any other
incentives related specifically to the transactions contemplated by this Agreement. Any such bonus or incentive payment shall require the prior written notice to Acquirors. All such bonus and incentive payments are set forth in Schedule
5.2(e). 
 (f) This Section 5.2 shall be binding upon and inure solely to the benefit of each of the parties, and nothing in
this Section 5.2, express or implied, shall confer upon any other Person any rights or remedies of any nature whatsoever under or by reason of this Section 5.2. Nothing contained herein, express or implied, shall be construed
to establish, amend or modify any benefit plan, program, agreement or arrangement. The parties acknowledge and agree that the terms set forth in this Section 5.2 shall not create any right in any Transferred Providers and Transferred
Management Employees or any other Person to any continued employment with Acquirors or its Affiliates or compensation, benefits or other terms and conditions of employment any nature or kind whatsoever. 

  
 -26- 

 5.3 Use of Purchased Assets. From and after the Closing, Seller shall not use, and
acknowledge that they will have no right or license to use, the Purchased Assets in any manner; provided, however, Seller may continue to use the name “Park Avenue Medical Associates, LLC” in connection with the collection of
Seller’s accounts receivable, as set forth on Schedule 1.1. Notwithstanding the foregoing, Seller shall, at its own expense and within thirty (30) days after Closing, cause the name “Park Avenue Medical Associates, LLC” to
be deleted from all signs, stationery, websites, advertising and other embodiments pertaining to the Business of Seller, and Seller shall have removed any reference to the Business or the Purchased Assets from any and all websites and marketing
materials and all websites of Seller shall have been redirected to a website designated in writing (which may be via electronic transmission) by Acquirors. In no event shall Seller use the name “Park Avenue Medical Associates, LLC” or any
other name in a manner adverse to Acquirors or their Affiliates. 
 5.4 Further Proceeds. Seller shall pay, upon receipt, to
Acquirors any payments Seller may receive from third parties in respect of the operation of any Acquired Assets subsequent to the Closing and any payments against accounts receivable of Acquirors arising subsequent to the Closing or in connection
with any services to be provided subsequent to the Closing which come into possession of Seller. Seller shall pay, upon receipt, to PC Buyer any payments Seller may receive from third parties in respect of the operation of any PC Acquired Assets
subsequent to the Closing Date and any payments against accounts receivable of PC Buyer arising subsequent to the Closing Date which come into the possession of Seller. Acquirors shall pay, upon receipt, to Seller, as applicable, any payments
Acquirors may receive from third parties in respect of the operation of any other Purchased Assets prior to the Closing Date and any payments against accounts receivable of Seller arising prior to the Closing Date (other than advances arising prior
to the Closing Date in connection with services to be provided subsequent to the Closing Date). 
 5.5 Audit; Access To Financial
Information. Subsequent to the Closing, each member of the Selling Group shall take or cause to be taken all action reasonably necessary upon notice during normal business hours at Acquirors’ sole cost and expense to allow Acquirors’
accountants, employees and other representatives access to Seller’s facilities, books, records and personnel in order that Acquirors may have full opportunity to make such inquiry as is necessary for the conduct and completion of a certified
audit of Seller’s financial position, results of operation and cash flows (“Financial Statements”) by the public accounting firm of Ernst & Young. Each member of the Selling Group agrees and acknowledges that Acquirors
have the right to include the Financial Statements in any filings or disclosures requested or required by any financial institution, stock market or exchange, contract or by Law (collectively “Filings”) and agree to execute any
consents required in connection with any such Filings. 
 5.6 Notice of Developments. Prior to the Closing, each party to this
Agreement shall give prompt written notice to each other parties of any act or omission causing a material breach of any of its representations and warranties in ARTICLE III or ARTICLE IV, as applicable. No disclosure by any such party
pursuant to this Section 5.6, however, shall be deemed to amend or supplement any disclosure the purpose of which is to limit the scope of or to prevent or cure any misrepresentation or breach of warranty, covenant or any provision of
this Agreement. 

  
 -27- 

 5.7 Public Announcements. Prior to the Closing, no party will issue or make any, press
release or report to the public with respect to this Agreement or the detailed financial transactions contemplated hereby without the prior consent of the other parties; provided, however, that Acquirors shall be permitted to issue one press release
prior to Closing, provided Selling Group consents to such press release, such consent not to be unreasonably withheld or delayed. If any party is unable to obtain the approval of its public press release, report or statement from the other parties
and such report, statement or release is, in the opinion of legal counsel to such party, required by Law in order to discharge such party’s disclosure obligations, then such party may make or issue the legally required report, statement or
release on prior notice and shall promptly furnish the other party with a copy thereof. 
 5.8 Tail Coverage. To the extent Seller
does not provide professional malpractice insurance for its Providers under an occurrence based policy, Seller shall provide evidence to Acquirors at or prior to Closing that Seller has acquired, or will acquire, in accordance with
Section 1.4 herein, professional malpractice tail coverage, satisfactory to Acquirors, at Seller’s sole expense, with respect to all Transferred Providers previously employed by or contracted with Seller and employed by or
contracted with PC Buyer immediately after Closing. If Seller holds occurrence-based malpractice coverage and provides occurrence-based professional malpractice coverage to its Providers, Seller shall provide evidence of such policy(ies). In the
event Seller does not provide such evidence to Acquirors by Closing, Acquirors shall procure said coverage on behalf of Seller’s Providers and shall remit the Tail Withhold to the relevant malpractice carrier or broker. Further, Seller shall be
responsible for professional malpractice tail coverage for itself. The cost of such professional malpractice insurance for itself and its Providers shall be at the sole cost and expense of Seller. 

5.9 Noncompetition and Nonsolicitation Provisions. Seller agrees, as permitted by applicable law, that it will transfer, convey, assign
and deliver to Acquirors all of the rights to enforce any remaining term of the noncompetition and nonsolicitation provisions of any agreement with any Provider, employee or independent contractor who does not enter into an employment agreement with
or whose employment agreement is not assigned to Buyer, PC Buyer or their Affiliate at the Closing to the extent transferable. 
 5.10
COBRA. On and after the Closing Date, Seller shall be responsible for (a) complying with all notice requirements of COBRA, and (b) providing COBRA continuation coverage to all “M&A qualified beneficiaries,” as that
term is defined by Treasury Regulations § 54.4980B-9, Q&A-4, with respect to the transactions contemplated by this Agreement for at least the maximum period that continuation coverage may be available to the M&A qualified
beneficiaries (including any second qualifying events experienced by the M&A qualified beneficiaries) under COBRA. 
 5.11 Kickbacks
and Referrals. 
 (a) Notwithstanding anything that may be explicitly or implicitly suggested to the contrary in this Agreement, the
parties shall not do any act prohibited by Section 1128B(b) of the Social Security Act. Without limiting the generality of the foregoing, neither Seller nor any Owner shall have any duty whatsoever to refer any individual, or arrange for any
individual to be referred, or recommend that any individual be referred, to PC Buyer for the furnishing or arranging for the furnishing of any item or service that may be paid for, in whole or in part, by a

  
 -28- 

 
Governmental Payment (as defined below). No part of the consideration under this Agreement is in any way intended or offered to produce or accomplish any transaction or relationship that is
prohibited by state or federal law and such an intention is vigorously disclaimed by all parties. For purposes hereof, a “Governmental Payment” shall mean any payment, in whole or in part, that is made under Title XVIII of the
Social Security Act (commonly known as Medicare) or under a State health care program under the Social Security Act (including Medicaid (Title XIX) and Titles V and XX). 

(b) The parties shall comply with the Stark Law and its implementing regulations. As long as either Seller or any Owner is considered to have
a “financial relationship” (as defined in 42 U.S.C. § 1395nn) with PC Buyer, then neither Seller nor any Owner shall make any referral to PC Buyer for the furnishing of “designated health services” (as defined in 42
U.S.C. § 1395nn) for which payment otherwise could be made under Title XVIII of the Social Security Act (Medicare) or, to the extent applicable as described in 42 U.S.C. § 1396, Title XIX of the Social Security Act (Medicaid),
unless an applicable exception is met. 
 (c) In the event that Seller or any Owner obtains an ownership interest or equity interest in an
Acquiror or any of its Affiliates or any entity that an Acquiror or any of its Affiliates has a direct or indirect financial interest in and is in a position to refer any “designated health services” (as defined in 42 U.S.C.
§ 1395nn) from an entity in which Seller or any Owner (or a member of his or her immediate family) has a financial interest to such entity, such referral shall not be made without the prior disclosure to and approval of Acquirors. The
ownership of a publicly traded security or mutual fund (as defined in 42 U.S.C. § 1395nn(c)) shall not be deemed an ownership or financial interest if such ownership qualifies for an exception under the Anti-Kickback Statute and/or the
Stark Law. No payment shall be made to Seller or any Owner that is intended to induce or that shall require the recommendation or referral of any patient, directly or indirectly, to any entity owned by any Acquiror or any Affiliate of an Acquiror
and further, is determined in any manner that takes into account the volume or value of business generated between the parties. 
 5.12
Operation of the Business until Closing. From the date of this Agreement through the Closing Date, Seller agrees to operate the Business in the normal course of business diligently, in compliance with all applicable Laws, and in substantially
the same manner as the Business has been carried out through the date of this Agreement. From the date of this Agreement through the Closing Date, Seller shall not sell or allow the creation of any Liens on the Purchased Assets, except as set forth
in Schedule 3.17. Seller shall not (a) engage in any activities or transactions which are outside the ordinary course of business of Seller as conducted prior to and as of the date of this Agreement; (b) alter or take any action to
alter its relationships with its suppliers, employees, independent contractors, Facilities, patients, referral sources or third party payors in such a way as to have a Material Adverse Effect, (c) amend its organizational documents;
(d) issue any additional equity securities or grant any option, warrant or right to acquire any equity securities or issue any security convertible into or exchangeable for such securities or alter in any way any of its outstanding equity
securities or make any change in outstanding equity securities or its capitalization, whether by reason of a reclassification, recapitalization, stock split or combination, exchange or readjustment of shares, dividend or otherwise; (e) fail to
keep in full force and effect insurance policies comparable in amount and scope to coverage maintained as of the date hereof; (f) take any other willful and knowing action 

  
 -29- 

 
that would result in a material breach of any representations and warranties made by Seller or any Owner in this Agreement; (g) settle, release or forgive any claim or litigation or waive
any right thereto; (h) enter into any transaction material to the Business, except in the ordinary course of business consistent with past practice; (h) increase the compensation or fringe benefits (including, but not limited to, vacation
or paid time off entitlement) of any present or former director, officer, employee, individual consultant or independent contractor of Seller, (i) grant any severance, bonus, change of control or termination payment to any present or former
director, officer, employee, individual consultant or independent contractor of Seller, (j) establish, adopt, enter into, amend or terminate any Employee Benefit Plan or any plan, agreement, program, policy, trust, fund or other arrangement
that would be a Employee Benefit Plan if it were in existence as of the date of this Agreement, (k) grant any equity or equity-based awards, (l) forgive or discharge in whole or in part any outstanding loans or advances to any present or
former director, officer, employee, individual consultant or independent contractor of Seller, or (m) agree, whether in writing or otherwise, to do any of the foregoing set forth in clauses (a) through (m). 

5.13 No Solicitation of Alternate Transaction. Between the date of this Agreement and the Closing Date, Seller shall not, and shall
ensure that, its directors, members, officers, partners, employees, independent contractors, consultants, counsel, accountants, investment advisors and other representatives and agents shall not, directly or indirectly, solicit offers from,
negotiate with, provide any nonpublic information to, enter into any agreement with, or in any manner encourage, accept or consider any proposal of, any third party relating to the acquisition of Seller, any of its assets (except in the ordinary
course of business) or Business, in whole or in part, whether through a tender offer (including a self-tender offer), exchange offer, merger, consolidation, sale of substantial assets or of a significant amount of assets, sale of securities,
acquisition of any of Seller’s securities, liquidation, dissolution or similar transaction involving Seller (each, a “Prohibited Transaction”). Seller shall promptly inform Acquirors of any such inquiry, the name of the third
party making such inquiry and the terms of any proposal. In the event Seller enters into a Prohibited Transaction, Seller shall reimburse Acquirors for all of its costs and expenses related to the transactions contemplated by this Agreement, without
limiting the other rights of Acquirors under any Law. 
 5.14 Custodian of Records. From and after Closing, Seller shall remain as
custodian of medical records of Seller, including all medical records related to the Business prior to the Closing. PC Buyer shall not assume any responsibility, and shall not be liable, to any third party related to Seller’s medical records or
protected health information. PC Buyer may examine, and at its expense, make copies of medical records as necessary in connection with the provision of medical services after the Closing. Seller shall provide PC Buyer with reasonable access to such
medical records during normal business hours, upon reasonable advance notice, to examine and make copies of the medical records, as necessary, to conduct the Business after Closing. Seller’s medical records, including all medical records
related to the Business prior to Closing, shall be Excluded Assets (as defined in Section 1.2). 
 5.15 Post-Closing
Operations of Acquirors. Selling Group acknowledges that, after the Closing, the Purchased Assets will be the sole and exclusive property of Acquirors. However, inasmuch as certain decisions that will be made by Acquirors can have a direct and
material effect on the Earnout Payment and Supplemental Earnout Payment, Acquirors agree to use their 

  
 -30- 

 
commercially reasonable efforts not to take actions that would materially and negatively affect the Earnout Payment and Supplemental Earnout Payment and will not make any such decisions unless in
their reasonable best judgment, after meaningful consultation with Sellers, such decisions are necessary in the context of the overall business objectives of the Acquirors and their Affiliates. Further, after the Closing, Acquirors agree to make
best efforts to implement an electronic health records (“EHR”) system or program in the Business and shall not unreasonably delay such implementation; provided, however, that Selling Group acknowledges and agrees that Acquirors
shall not be liable to Selling Group for failure to implement or any delay in implementation of an EHR system or program, or to any liability related to the earning of any federal incentive payments related to the implementation of such EHR system.

 5.16 Assignment of Agreements. Within sixty (60) days of the Closing Date, Seller shall cause all of those certain Contracts
(as set forth Schedule 3.8(b)(1) – (98).), to be either terminated or assigned to PC Buyer. 
 ARTICLE VI 

SURVIVAL; INDEMNIFICATION 

6.1 Survival. All representations and warranties of Acquirors and each of the entities and individuals in the Selling Group contained
in this Agreement shall survive the Closing and shall remain in full force and effect for the longer of any applicable statute of limitations or a period of two (2) years after the Closing; provided, however, that the representations and
warranties set forth in Sections 3.1 (Organization), 3.2 (Authority Relative to this Agreement), 3.3 (No Violation), 3.4 (Purchased Assets), 3.7 (ERISA; Benefit Plans), 3.10 (Compliance with Laws), 3.12
(Taxes), 3.16 (Broker Fees), 3.19 (Certain Payments), 3.20 (Designated Health Services), 4.1 (Organization of Acquirors), 4.2 (Authority Relative to this Agreement), 4.3 (No Violation) and 4.5 (Broker
Fees) (collectively, the “Fundamental Representations”) shall survive the Closing and shall remain in full force and effect until the expiration of the applicable statute of limitations. Notwithstanding any right of any party to
investigate fully the affairs of another party, and notwithstanding any knowledge of facts determined or determinable by any party pursuant to such investigation or right of investigation, each party has the right to rely fully upon the
representations, warranties, covenants, agreements of any other party contained in this Agreement or in any certificate or other document delivered pursuant to or in connection with the transactions contemplated by this Agreement. Covenants of
Acquirors and each of the entities and individuals in the Selling Group that contemplate or may involve actions to be taken or obligations in effect after the Closing shall survive the Closing in accordance with their terms, or if no term is
specified, for two (2) years following the Closing. Any claims for indemnification under this Section 6.1 must be made, if at all, within the applicable survival period set forth in this Section 6.1. 

6.2 Indemnification. From and after the Closing, the parties to this Agreement shall indemnify each other as set forth below. 

(a) Seller and each Owner shall, jointly and severally, indemnify, defend and hold harmless each of the Acquirors and each of Acquirors’
respective shareholders, officers, directors, employees, agents and affiliates (the “Acquiror Indemnitees”), from and against any and all losses, damages, Liabilities and claims (“Losses”) arising out of, based
upon, or resulting from any or all of (i) the Excluded Assets; (ii) the Excluded Liabilities; (iii) any action, claim or 

  
 -31- 

 
proceeding, whether brought or threatened, by any future, current or former equity owner of Seller or beneficiary of any Owner or any relative or Affiliate of any such future, current or former
equity owner of Seller or beneficiary of any Owner; (iv) any Liability, other than the Assumed Liabilities, of any member of the Selling Group (including any Liability of any Acquiror under any bulk transfer law, any common law or other legal
doctrine of de facto merger or successor liability, or otherwise by operation of Law) and any Liability for Taxes of any member of the Selling Group; (v) any inaccuracy as of the Closing, or at any time thereafter during the applicable survival
period as specified in Section 6.1, of any representation or warranty of Seller which is contained in this Agreement or any document contemplated to be delivered in connection with or pursuant to this Agreement, including the
Noncompetition Agreements; (vi) any Liability of Seller in connection with ERISA or Employee Benefit Plans; (vii) other than the Assumed Liabilities, any Liability of Seller related to employees or independent contractors of Seller,
including workers’ compensation claims, severance payments, claims related to ownership, or compensation accrued prior to the Closing; (viii) any breach or nonfulfillment by any member of the Selling Group of any of its, his, her or their
covenants, agreements or other obligations contained in or made pursuant to this Agreement or any agreement contemplated to be delivered in connection with or pursuant to this Agreement, including the Noncompetition Agreements; (ix) any
Liability of any member of the Selling Group for a brokerage fee, commission or finder’s fee in connection with the transaction contemplated by this Agreement resulting from a breach of Section 3.16 hereof; (x) any Liability
arising from the collection of the accounts receivables of Seller; (xi) any Liability arising from or relating to Seller’s or any Owner’s participation in a governmental or other healthcare program which is or may be asserted before
or after the Closing including but not limited to audits, investigations, reviews, overpayments, damages, fines, penalties, costs of investigations, necessary audits and any prospective compliance obligations imposed on any Acquiror including any
claims of successor liability resulting from Seller’s or any Owner’s operation of the Business prior to the Closing; (xii) any Liability arising from or relating to any Liens, loans or other forms of indebtedness of any member of the
Selling Group; (xiii) any Liability arising from or relating to the operation of the Business prior to the Closing, including any malpractice claims arising from or related to professional services rendered prior to the Closing; (xiv) any
Liability arising from or relating to the allocation and distribution of the Purchase Price among the Selling Group; and (xv) any Liability arising from or relating to any negotiations or discussions between and among Seller and/or any Owner,
or an Affiliate of Selling Group, and potential target entities for acquisition, unless such action was conducted directly by Acquirors, including any discussions or negotiation prior to the Closing between Seller and/or any Owner or an Affiliate of
Seller and Malden Primary Care. Seller and Owners shall reimburse Acquirors for any and all fees, costs and expenses of any kind related to any Losses (including any and all Legal Expenses (as defined below)) and, for purposes hereof, such fees,
costs and expenses shall be deemed to be Losses. “Legal Expenses” of a person shall mean any and all fees, costs and expenses of any kind reasonably incurred by such person, including reasonable legal fees incurred in defending
against any threatened or asserted claim. 
 (b) Acquirors shall, jointly and severally, indemnify, defend and hold harmless each individual
and entity in the Selling Group and each such individual and entity’s respective members, officers, directors, employees, agents and affiliates from and against any and all Losses arising out of, based upon or resulting from (i) any
inaccuracy as of the Closing, or at any time thereafter during the applicable survival period as specified in Section 6.1, of any 

  
 -32- 

 
representation or warranty of any Acquiror which is contained in this Agreement or any document delivered in connection with or pursuant to this Agreement, including the Noncompetition
Agreements; (ii) any breach or nonfulfillment by any Acquirors of any of its covenants, agreements or other obligations contained in or made pursuant to this Agreement; (iii) any Liability arising after the Closing in connection with the
use or operation of the Purchased Assets after the Closing, or other conduct of the Business, by Acquirors subsequent to the Closing; and (iv) any Assumed Liability. Acquirors shall reimburse Seller for any and all fees, costs and expenses of
any kind related to any Losses (including, without limitation, any and all Legal Expenses) and, for purposes hereof, such fees, costs and expenses shall be deemed to be Losses. 

(c) Promptly after receipt by any Person entitled to indemnification under this Section 6.2 (an “Indemnified
Party”) of notice of the commencement of any action by a third party in respect of which the Indemnified Party will seek indemnification hereunder, or knowledge of an Indemnified Party of any basis for a claim for indemnification hereunder
not involving a third party claim (and in no event more than sixty (60) days after receipt of such notice or the discovery of facts giving rise to such knowledge), the Indemnified Party shall notify each Person that is obligated to provide such
indemnification (an “Indemnifying Party”) thereof in writing; provided, however, that any failure to so notify the Indemnifying Party shall not relieve it from any Liability that it may have to the Indemnified Party
other than to the extent the Indemnifying Party is prejudiced thereby. With respect to a claim for indemnification involving an action brought by a third party and as to which the Indemnifying Party has acknowledged in writing its responsibility to
provide indemnification pursuant to this Section 6.2, the Indemnifying Party shall be entitled to control the defense of such action with counsel reasonably satisfactory to the Indemnified Party; provided, however, that the
Indemnifying Party shall actively and diligently pursue such defense on behalf of Indemnified Party, the Indemnified Party shall be entitled to participate in the defense of such claim and to employ its own counsel at its own expense to assist in
the handling of such claim. The Indemnifying Party shall obtain the prior written approval of the Indemnified Party before entering into any settlement of such claim or ceasing to defend against such claim (with such approval not to be unreasonably
withheld); and no Indemnifying Party shall consent to the entry of any judgment or enter into any settlement that does not include as an unconditional term thereof the giving by each claimant or plaintiff to each Indemnified Party of a release from
all Liability in respect of such claim. If the Indemnifying Party does not assume control of defense of such action as provided in this Section 6.2, the Indemnified Party shall have the right to defend such action in such manner as it
may deem appropriate at the cost and expense of the Indemnifying Party, and the Indemnifying Party will reimburse the Indemnified Party therefor in accordance with this Section 6.2. 

(d) In the event the Indemnified Party should have a claim against the Indemnifying Party hereunder which does not involve a claim or demand
being asserted against or sought to be collected by a third party, the Indemnified Party shall with reasonable promptness send a notice of such claim the Indemnifying Party. If the Indemnifying Party does not notify the Indemnified Party within
thirty (30) days after receipt of the notice that that the Indemnifying Party disputes such claim, the amount of such claim shall be conclusively deemed a liability of the Indemnifying Party hereunder. If the Indemnifying Party does notify the
Indemnified Party in writing that it disputes such claim within such thirty (30) day period, the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party on the terms and subject to the provisions of
this Agreement. 

  
 -33- 

 (e) In the event that the Indemnifying Party shall be obligated to indemnify the Indemnified
Party pursuant to this Section 6.2, the Indemnifying Party shall, upon payment of such indemnity in full, be subrogated to all rights of the Indemnified Party with respect to the claims to which such indemnification relates. 

6.3 Limitation on Liability. 

(a) Basket. The obligation of Seller and Owners to indemnify the Acquiror Indemnitees under Section 6.2(a)(v) will only
arise once the aggregate of such Losses incurred by the party seeking indemnification exceeds One Hundred Fifty Thousand Dollars ($150,000) (the “Basket Amount”). If the Basket Amount is met, the Indemnifying Party shall thereafter
indemnify against and compensate and reimburse for the amount of Losses in excess of the initial Fifty Thousand Dollars ($50,000) incurred by the party seeking indemnification. 

(b) Cap. The aggregate liability or obligation of Seller and Owners to indemnify the Acquiror Indemnitees under
Section 6.2(a)(v) shall not, in the aggregate, exceed One Million Dollars ($1,000,000) (the “Cap”). 
 (c)
Notwithstanding the foregoing, in no event shall Section 6.3(a) or Section 6.3(b) apply to any Losses suffered or incurred by Acquirors as a result, directly or indirectly, of any of the following: (i) any breach of the
Fundamental Representations; (ii) Seller’s willful and/or intentional misrepresentation or fraud; or (iii) any Excluded Liability. 

6.4 Effect of Investigation; Waiver. An Indemnified Party’s right to indemnification or other remedies based upon the
representations, warranties, covenants and agreements of the Indemnifying Party will not be affected by any investigation or knowledge of the Indemnified Party or any waiver by the Indemnified Party of any condition based on the accuracy of any
representation or warranty or compliance with any covenant or agreement. Such representations and warranties and covenants and agreements shall not be affected or deemed waived by reason of the fact that the Indemnified Party knew or should have
known that any representation or warranty might be inaccurate or that the Indemnifying Party failed to comply with any agreement or covenant. Any investigation by such party shall be for its own protection only and shall not affect or impair any
right or remedy hereunder. 
 6.5 Set-Off Right. An indemnification claim to recover Losses by set off from amounts otherwise payable
by Acquirors pursuant to this Agreement shall be subject to the provisions of this Section 6.5. The Indemnified Party shall provide written notice to Seller, specifying in reasonable detail the basis for a claim of set-off. Seller shall
have thirty (30) days from delivery of notice to respond to such notice (the “Response Period”). If Seller consents in writing to the set-off or fail to respond during the Response Period, the applicable Acquiror may set off
any amount to which such Acquiror may be entitled under this ARTICLE VI against amounts otherwise payable by such Acquiror pursuant to this Agreement and shall remit such amount to the Indemnified Party. If Seller provides written notice to
the Indemnified Party disputing the proposed set-off, the parties shall attempt in good faith to resolve the dispute related to the set-off. Neither the exercise of, nor the failure to exercise, such right of set off will

  
 -34- 

 
constitute an election of remedies nor limit in any manner the enforcement of any other available remedies. The exercise of the right of set-off by Acquirors in accordance with this
Section 6.5 will not constitute a breach of this Agreement or any other agreement or instrument contemplated by this Agreement. In the event the parties fail to agree on the proposed set-off, either party shall have the right to submit
the dispute to arbitration pursuant to Section 8.15 herein. 
 ARTICLE VII 

TERMINATION AND ABANDONMENT 

7.1 Termination. This Agreement may be terminated and the transactions contemplated herein may be abandoned at any time prior to the
Closing only: 
 (a) by mutual consent of Acquirors, on the one hand, and Seller, on the other hand; 

(b) by Seller if any of the conditions specified in Section 2.2 hereof have not been met or waived by Seller at such time as such
condition can no longer be satisfied; 
 (c) by Acquirors, if any of the conditions specified in Section 2.1 hereof has not been
met or waived by Acquirors at such time as such condition can no longer be satisfied; 
 (d) by (i) Acquirors, if Seller shall fail to
perform in any material respect, its agreements contained herein required to be performed prior to Closing, or materially breach (that is, a breach which would be subject to indemnification under ARTICLE VI) any of its representations,
warranties or covenants contained herein, in each case in writing, without liability to the terminating parties on account of such termination (provided the terminating parties are not otherwise in material default or in material breach of this
Agreement); or (ii) Seller, if Acquirors shall fail to perform in any material respect its agreements contained herein required to be performed prior to Closing, or materially breach (that is, a breach which would be subject to indemnification
under ARTICLE VI) any of its representations, warranties or covenants contained herein, in each case in writing, without liability to the terminating parties on account of such termination (provided the terminating parties are not otherwise
in material default or in material breach of this Agreement); or 
 (e) by either party if the Closing Date does not occur on or prior to
December 16, 2013. 
 7.2 Procedure and Effect of Termination. In the event of termination by Acquirors, on the one hand, or
Seller, on the other hand, pursuant to Section 7.1, written notice thereof shall immediately be given to the other parties and this Agreement shall terminate and the transactions contemplated hereby shall be abandoned without further
action by any of the parties hereto. Notwithstanding the foregoing, the obligations set forth in Section 5.7 (Public Announcement), ARTICLE VIII (Miscellaneous), this Section 7.2 and the obligations contained in that
certain Nondisclosure Agreement executed on April 4, 2010, by and between an Affiliate of Seller and an Affiliate of Acquirors, shall survive termination of this Agreement, and nothing herein shall relieve any party from its obligations with
respect to any breach of this Agreement occurring prior to a termination. In such event, each party shall, upon request, return all documents, work papers and other material of any other party (and all copies thereof) relating to the transactions
contemplated herein, whether so obtained before or after the execution hereof, to the party furnishing the same. 

  
 -35- 

 ARTICLE VIII 

MISCELLANEOUS 
 8.1
Expenses. Except as otherwise provided in this Agreement, each of the parties hereto shall pay its, his or her own fees and expenses (including the fees of any attorneys, accountants, investment bankers, advisors or others engaged by such
party) in connection with this Agreement and the transactions contemplated hereby whether or not the transactions contemplated hereby are consummated. 

8.2 Headings. Headings herein are for convenience of reference only, do not constitute part of this Agreement, and shall not be deemed
to limit or otherwise affect any of the provisions hereof. 
 8.3 Notices. All notices or other communications required or permitted
hereunder shall be given in writing and shall be deemed given if delivered by hand (including by courier), mailed by registered or certified mail, postage prepaid (return receipt requested), sent by nationally recognized overnight courier providing
a delivery receipt, or sent by facsimile or other electronic means, to the address or facsimile number as set forth on the signature pages hereto or such other address or facsimile number as shall be furnished in writing by such party, and any such
notice or communication shall be effective and be deemed to have been given as of the date so delivered or, if mailed upon receipt thereof, or if sent by facsimile, or other electronic means, on production of a transmission report by the machine
from which it was sent which indicates that the notice was sent successfully in its entirety, and received by, to the recipient; provided, however, that any notice or communication changing any of the addresses or facsimile numbers set
forth above shall be effective and deemed given only upon its receipt. 
 8.4 Assignment. This Agreement and all of the provisions
hereof shall be binding upon and inure to the benefit of the parties hereto and their respective successors and permitted assigns, and the provisions of ARTICLE VI shall inure to the benefit of the Indemnified Parties referred to therein;
provided, however, that neither this Agreement nor any of the rights, interests or obligations of the parties hereunder may be assigned by any of the parties without the prior written consent of the other parties. 

8.5 Entire Agreement. This Agreement (including the Schedules and Exhibits attached hereto which are incorporated herein) embodies the
entire agreement and understanding of the parties with respect to the transactions contemplated hereby and supersedes all prior or contemporaneous written or oral agreements, commitments, arrangements or understandings with respect thereto including
that certain letter of intent dated June 19, 2013, by and among the Selling Group and an Affiliate of Acquirors, but excluding that certain Nondisclosure Agreement executed as of April 9, 2010, by and between an Affiliate of Seller and an
Affiliate of Acquirors and such other documents executed contemporaneously with this Agreement. 

  
 -36- 

 8.6 Counterparts; Facsimile Transmission. This Agreement may be executed in any number of
counterpart signature pages each of which shall be deemed to be an original and all of which together shall constitute one and the same original instrument. This Agreement and its counterparts may be executed and delivered by facsimile transmission
with confirmation of received transmission or other electronic means that faithfully reproduces the original with same effect as if a manually signed original were personally delivered. 

8.7 Confidentiality. No party shall issue any press release or announcement or make any disclosure to any other Person (other than its
counsel, financial advisors and accountants) relating to the subject matter of this Agreement without the prior written approval of Acquirors and the Selling Group; provided, however, that any party may make any public disclosure it believes in good
faith is required by Law, legal process or contract or the requirements of any stock market on which such party’s (or such party’s parent corporation’s), capital stock is listed or quoted (in which case the disclosing party shall
advise the other parties of such disclosure and provide them with a copy of such disclosure). Notwithstanding the foregoing, following the Closing, Acquirors or their Affiliates shall have the right to issue a press release or other announcement
announcing the consummation of the transactions contemplated by this Agreement. 
 8.8 Governing Law. This Agreement shall in all
respects be interpreted, construed and governed exclusively by and in accordance with the Laws of the State of New York; provided, however, that each right transferred under Section 5.9 of this Agreement (relating to the enforcement of
noncompetition and nonsolicitation provisions) will be governed by the choice of law provision contained in the agreement wherein such noncompetition and nonsolicitation provisions are set forth. 

8.9 Certain Definitions. 

(a) An “Affiliate” or “affiliate” of a specified Person is a Person, that directly or indirectly, through one
or more intermediaries, controls, is controlled by, or is under common control with the Person specified. As used in this definition, “control” (including, with correlative meanings, “controlled by” and
“under common control with”) shall mean possession, directly or indirectly, of power to direct or cause the direction of management or policies of the specified Person (whether through ownership of securities or other ownership
interest, by contract or otherwise). 
 (b) “Acquirors’ Knowledge” means (i) the actual knowledge of Adam
Singer, M.D. and R. Jeffrey Taylor as to the matter to which the knowledge relates; and (ii) any additional knowledge that would be available to such persons after making such inquiry into such matter as a reasonable person seeking to
accurately, truthfully and completely address such matter would have made under the circumstances applicable to such matter. 
 (c)
“Business” shall mean any of the following: (i) the arranging for and/or provision of Facilities-based medical care and associated services for patients of other physicians, or for patients who do not have a primary care
physician while such patients are in Facilities (whether or not such patients are referred via an arms-length contractual relationship with a Facility or a payor); (ii) the arranging for and/or provision of more than a Provider’s pro rata
share of emergency room, department, or Facility coverage at a Facility if a Provider is required to provide such coverage by contractual arrangement or by the Facility’s medical staff bylaws, policies, or procedures generally applicable to
members of such Facility’s medical staff; 

  
 -37- 

 
(iii) the arranging for and/or provision of medical care and associated services by a Provider for patients in a skilled nursing facility, nursing home, assisted living facility, hospice, or
adult care home where such Provider is acting as a primary caregiver; (iv) the arranging for and/or provision of emergency room, department, or Facility coverage at a Facility which does not require such coverage by its medical staff bylaws,
policies, or procedures; (v) the development and implementation of programs to provide and/or manage Facilities-based medical care; (vi) the provision of billing, management, medical director, or other services or software to any such
Facilities or programs; (vii) the development and implementation of programs to manage Facilities-based medical care and associated services for patients of other physicians, or for patients who do not have a primary care physician while such
patients are in Facilities; and (viii) the provision of billing, management or other non-clinical administrative services or software to any such Facilities or Facility-based programs. 

(d) “COBRA” means Part 6 of Subtitle B of Title I of ERISA, Code §4980B, and any similar state Law. 

(e) “Code” means the United States Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.

 (f) “Employee Benefit Plan” means (i) each “employee benefit plan” (as defined in ERISA §3(3)) and
(ii) any other arrangement, obligation, plan, program or practice, whether or not legally enforceable, to provide benefits or compensation, other than currently-paid salary, as compensation for services rendered, to one or more present or
former employees, directors, agents, or independent contractors, that is maintained, sponsored, contributed to (or required to be contributed to) by Seller or any ERISA Affiliate, or for which Seller or any ERISA Affiliate otherwise has or may have
any Liability, contingent or otherwise, including employment agreements, offer letters, severance policies, programs or agreements, post-employment arrangements, change in control agreements, executive compensation arrangements, deferred
compensation arrangements, incentive arrangements, consulting or other compensation arrangements, bonus plans, phantom stock or equity plans, tuition reimbursement programs or scholarship programs, Section 529 plans, health or medical benefits,
insurance (including self-insurance), disability or sick leave, any plans subject to Section 125 of the Code or any comparable provision of any other applicable Law, any plans providing benefits or payments in the event of a change of ownership
or control, and each other employee benefit plan, fund, program, agreement or arrangement. 
 (g) “Environmental Law” means
any common law principle or Law of any governmental authority relating to the environment or public health and safety, including any statute, regulation or order pertaining to any of the following: (i) treatment, storage, disposal, generation
and transportation of toxic or hazardous substances or solid or hazardous waste; (ii) air, water and noise pollution; (iii) groundwater and soil contamination; (iv) the release or threatened release into the environment of toxic or
hazardous substances, or solid or hazardous waste, including emissions, discharges, injections, spills, escapes or dumping of pollutants, contaminants or chemicals; (v) the protection of wild life, marine sanctuaries and wetlands, including all
endangered and threatened species; (vi) underground and other storage tanks or vessels, abandoned, disposed or discarded barrels, containers and other closed receptacles; (vii) public health and safety; and (viii) manufacture,
processing, use, distribution, treatment, storage, disposal, transportation or handling of pollutants, contaminants, chemicals or industrial, 

  
 -38- 

 
toxic or hazardous substances or oil or petroleum products or solid or hazardous waste. As used above, the terms “release” and “environment” have the meanings set forth in the
Comprehensive Environmental Response, Compensation and Liability Act of 1980, as amended. 
 (h) “Escrow Deposit” shall
mean an amount of Five Hundred Thousand Dollars ($500,000) which shall be deducted from the Closing Payment and remain with the Escrow Agent for a period of two (2) years following the Closing unless earlier disbursed pursuant to the Escrow
Agreement. 
 (i) “Facility” or “Facilities” means short-term and long-term acute care hospitals and long
term care facilities, including but not limited to, rehabilitation hospitals, skilled nursing facilities, nursing homes, assisted living facilities, adult foster care homes, hospice facilities and programs and other long term care or residential
facilities. 
 (j) “Immediately Available Funds” shall mean good funds delivered by wire transfer to an account designated
by the intended recipient. 
 (k) “Including” or “includes” shall be deemed to mean “including,
without limitation” and “includes, without limitation.” 
 (l) “Intellectual Property” means
(i) inventions (whether patentable or unpatentable and whether or not reduced to practice), and all improvements thereto; (ii) trademarks, service marks, logos, trade names, Internet domain names and websites, and corporate names, together
with all translations, adaptations, derivations and combinations thereof and including all goodwill associated therewith, and all applications, registrations and renewals in connection therewith, copyrightable works, all copyrights and all
applications, registrations and renewals in connection therewith; (iii) trade secrets and confidential business information (including, but not limited to, data, know-how, customer lists, current and anticipated customer requirements, price
lists, market studies and business plans), however documented; (iv) proprietary computer software and programs (including object code and source code) and other proprietary rights and copies and tangible embodiments thereof (in whatever form or
medium); (v) database technologies and systems (and related processes, formulae, compositions, improvements, devices, know-how, inventions, discoveries, concepts, ideas, designs, methods and information) and any other related information,
however documented; (vi) all databases and data collections and all rights therein; and (vii) any similar or equivalent rights to any of the foregoing anywhere in the world. 

(m) “Law” or “Laws” means, collectively, all federal, state and local laws, statutes, codes, ordinances,
orders, decrees, rulings, rules and regulations, including judicial opinions. 
 (n) “Liability” or
“Liabilities” shall mean any liability or obligation of whatever kind or nature (whether known or unknown, whether asserted or unasserted, whether absolute or contingent, whether accrued or unaccrued, whether liquidated or
unliquidated, and whether due or to become due). 

  
 -39- 

 (o) “Lien” or “Liens” shall mean any pledge, lien
(including any Tax lien), charge, claim, encumbrance, security interest, deed of trust, mortgage, or outstanding tax obligations. 
 (p)
“Material Adverse Effect” shall mean any change, effect, event, occurrence, state of facts, or development that, individually or in the aggregate with any other change, effect, event, occurrence, state of facts, or development, is
materially adverse to the financial condition or results of operations of the entity or entities taken as a whole; provided, however, that none of the following shall be deemed in itself, or in any combination, to constitute, and none
of the following shall be taken into account in determining whether there has been or will be, a Material Adverse Effect: (i) any adverse change, effect, event, occurrence, state of facts, or development attributable to conditions affecting
providers of Facility based medical services, the United States economy as a whole or the capital markets in general or the markets in which the party operates; (ii) any adverse change, event, development or effect arising from or relating to
changes in Generally Accepted Accounting Principles; (iii) any adverse change, event, development or effect arising from or relating to changes in Law, rules, regulations, orders or other binding directives issued by any governmental authority;
(iv) any adverse change, effect, event, occurrence, state of facts, or development arising from or relating to the commencement, continuation or escalation of a war, material armed hostilities or other material international or national
calamity or act of terrorism directly or indirectly involving the United States; and (v) the announcement of the transactions contemplated hereby; (vi) actions or omissions of, or on behalf of, the other party; other than, in the case of
clauses (i) through (iv), to the extent such circumstances affect the party in a disproportionate manner as compared to other businesses in the industry in which such party operates. 

(q) “Person” or “person” shall mean an individual or any corporation, partnership, joint venture,
association, limited liability company, trust, unincorporated organization or other legal entity or a government or governmental entity; 

(r) “Personal Goodwill” shall mean the business created or developed by the Owners, or by or through their personal
reputation, contacts or relationships, or otherwise possessed by the Owners in connection with the management and operation of the Business, including the Owners’ personal business relationships with referral sources, customers, suppliers and
any others having business relationships with Seller. 
 (s) “Provider” shall mean a Person who has met, or is obligated to
meet, the requirements of the appropriate state authority (e.g., state agency, professional board), and has, or is required to have, a current license issued by such state authority to provide professional services as a medical doctor, doctor of
osteopathy, doctor of psychology, nurse practitioner, physician assistant, or clinical social worker, as applicable. 
 (t) “Revenue
Contracts” shall mean, to the extent Seller is a party thereto or a beneficiary thereof, all contracts to provide healthcare services, including medical directorship and other administrative services, as set forth in Attachment 2 to
Schedule 1.1. 
 (u) “Selling Group’s Knowledge” means (i) the actual knowledge of any Owner, or Brad
Markowitz, or Marianne Rattray as to the matter to which the knowledge relates; and (ii) any additional knowledge that would be available to such persons after making such inquiry into such matter as a reasonable person seeking to accurately,
truthfully and completely address such matter would have made under the circumstances applicable to such matter. 

  
 -40- 

 (v) “Tax” or “Taxes” shall mean any federal, state, local or
foreign income, gross receipts, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental, customs duties, capital stock, franchise, profits, withholding, social security (or similar), unemployment,
disability, real property, personal property, abandoned property, escheat, sales, use, transfer, registration, value added, alternative or add-on minimum, estimated, or other tax of any kind whatsoever, whether computed on a separate or
consolidated, unitary or combined basis or in any other manner, including any interest, penalty, or addition thereto, whether disputed or not and including any obligation to indemnify or otherwise assume or succeed to the Tax liability of any other
Person. 
 (w) “Tax Return” shall mean all returns, declarations, reports, estimates and information statements and returns
required or permitted to be filed with a governmental authority relating to Taxes, including, but not limited to, original returns and filings, amended returns, claims for refunds, information returns, ruling requests, administrative or judicial
filings, accounting method change requests, responses to revenue agents’ reports (federal, state, foreign, municipal or local) and settlement documents, and any schedules attached to any of the foregoing. 

8.10 Severability. If any one or more of the provisions of this Agreement shall be held to be invalid, illegal or unenforceable, the
validity, legality or enforceability of the remaining provisions of this Agreement shall not be affected thereby and this Agreement will be construed and enforced as if such invalid, illegal or unenforceable provisions had not been included herein.
To the extent permitted by applicable law, each party waives any provision of law which renders any provision of this Agreement invalid, illegal or unenforceable in any respect. 

8.11 Remedies. The parties hereto recognize that any breach of the terms of this Agreement may give rise to irreparable harm for which
money damages would not be an adequate remedy, and accordingly agree that, in addition to the indemnification remedies set forth in ARTICLE VI hereof, any non-breaching party shall be entitled to enforce the terms of this Agreement by a
decree of specific performance and the non-defaulting party shall be entitled to recover its costs and expenses, including reasonable attorneys fees, incurred as a result of the defaulting party’s breach. 

8.12 Amendment; Waiver. The parties may, only by written agreement, modify, amend or supplement any term or provision of this
Agreement, and any term or provision of this Agreement may be waived by the party which is entitled to the benefit thereof. Any waiver pursuant to this Agreement shall be in writing and shall be effective only in the specific instance and for the
purpose for which given. No failure or delay on the part of any party in exercising any right, power or privilege under this Agreement shall operate as a waiver thereof nor shall any single or partial exercise of any right, power or privilege
hereunder preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies expressly specified in the Agreement are cumulative and are not exclusive of any rights or remedies which any
party would otherwise have. 

  
 -41- 

 8.13 Third Parties. Nothing in this Agreement shall be deemed to be for the benefit of, or
enforceable by or on behalf of any Person other than the parties to this Agreement or their Affiliate, which shall be deemed third party beneficiaries of this Agreement, and the Indemnified Parties. 

8.14 Attorneys’ Fees. If any party files a suit or an action, or commences any proceeding (whether in arbitration, mediation or
otherwise), to enforce the provisions of this Agreement or otherwise with respect to the subject matter of this Agreement, the prevailing party shall be entitled to recover its reasonable attorneys’ fees as fixed by the court or arbitrator.

 8.15 Arbitration. The parties agree to submit any controversy, claim or dispute arising out of or relating to the interpretation,
performance or breach of this Agreement, including the scope of this arbitration provision and the parties’ compliance with their obligations under this Section 8.15 to binding arbitration administered by the American Arbitration
Association (“AAA”) in its New York, New York regional office in accordance with AAA Rules and Procedures, as modified by the specific provisions set forth in this Section 8.15. In the event of any conflict between AAA
Rules and Procedures and the specific provisions set forth in this Section 8.15, the provisions of this Section 8.15 shall prevail. 

(a) Notice of Grievance. Before submitting any controversy, claim or dispute to arbitration, any parties claiming to be aggrieved shall
deliver to the other parties, in the same manner provided in this Agreement for the delivery of notices, a written statement of the alleged grievance identifying any documents then reasonably known to that party that support the grievance and the
relief requested or proposed. If, within thirty (30) days after delivery of the written statement of grievance, the other parties do not agree to furnish the relief requested or proposed, or otherwise does not satisfy the demand of the party
claiming to be aggrieved, then the parties claiming to be aggrieved may demand arbitration in accordance with this Section 8.15. 

(b) Selection of Arbitrator. The arbitration shall take place before a single arbitrator who shall be selected jointly by both parties.
If the parties are unable to agree within fifteen (15) days each party shall submit a list of three (3) arbitrators from the AAA panel to the other party. Each party may strike two (2) from the list. AAA shall make the final selection
of the arbitrator from the two (2) remaining names. 
 (c) Power of Arbitrator In addition to all other powers the arbitrator
enjoys under this Agreement, AAA Rules and Procedures, AAA Code of Ethics and the laws of the State of New York, the arbitrator expressly shall have all jurisdiction and power to make rulings as to procedures for the conduct for the arbitration; to
declare rights of the parties, and to grant temporary and permanent injunctive and other equitable relief; to order specific performance of contractual obligations; to grant compensatory and punitive damages; to determine the admissibility,
relevance, materiality and weight of any evidence offered by any of the parties (provided, that mere affidavits without the ability of a party to examine the affiant shall not be admissible); and to take any interim measure with respect to the
subject matter in dispute, including but not limited to, measures to facilitate or compel discovery and measures to conserve the rights, funds, goods or materials forming the subject matter in dispute. The decision of the arbitrator shall be in
accordance with the substantive laws of the State of New York. The parties may apply for confirmation and/or enforcement of any arbitration award hereunder to the Courts of the State of New York or of such other state, locality, country or territory
as may have jurisdiction over the party or parties subject to the award. 

  
 -42- 

 (d) Discovery. Each party shall have the right to conduct discovery in the manner and to
the extent authorized by the Federal Rules of Civil Procedure as interpreted by the federal courts. 
 (e) Arbitrator’s Award.
The arbitrator’s award shall state the factual and legal basis for the award. The arbitrator’s award shall be final and binding on the parties, and judgment on the award may be entered in any court of competent jurisdiction. 

(f) Cost of Arbitration. The cost of the arbitration, including arbitrator’s fees, shall initially be shared equally by the
parties. The arbitrator shall award the prevailing party costs of the arbitration in the award, including the prevailing party’s Legal Expenses. The term “costs” includes the fees of the arbitrator, but remains within the sole
discretion of the arbitrator as to the awarding of any specific item (other than reasonable attorneys’ fees and costs). 
 8.16
Attorney and Tax Advisor Approval. The parties acknowledge that each of them have had the opportunity to have this Agreement and the related documents described herein reviewed by their own counsel and the terms and conditions of same have
been deemed satisfactory by all parties. In addition, all parties acknowledge that each of them have had the opportunity to have the tax consequences of the transactions contemplated herein and the other related agreements reviewed by their own tax
advisors and are not relying on the other parties or their advisors for any such review or tax advice. 
 8.17 Time. The parties
acknowledge and agree that time shall be of the essence in this Agreement. 
 8.18 Bulk Sales. If applicable, Acquirors and Seller
hereby waive compliance with the bulk sales Laws and any other similar Laws in any applicable jurisdiction in respect of the transactions contemplated by this Agreement; provided, however, that Seller shall pay and discharge when due,
and agree to hold harmless and indemnify Acquirors against any Losses arising from or otherwise relating to, all claims of creditors (including any taxing authority) asserted against any Acquiror, the Business or the Purchased Assets by reason of
such noncompliance and shall take promptly all necessary actions required to remove any Lien which may be placed upon any of the Purchased Assets by reason of such noncompliance. 

(Signature Pages Follow) 

  
 -43- 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the day and
year first above written. 
  

					
	PC BUYER:	 	 	 	 IPC HOSPITALISTS OF NEW

ENGLAND, P.C.

			
	 Address for Notice:
  

4605 Lankershim Blvd., Suite 617
	 		 	  
 Adam Singer, M.D.

President

	 North Hollywood, CA 91602
 Attention: Chief
Executive Officer
 FAX: 818-766-9781
	 		 	
			
	 with a copy to (which shall not constitute notice):
  

4605 Lankershim Blvd., Suite 617
 North Hollywood, CA 91602

Attention: Vice President of Legal Affairs
 FAX:
818-509-8186
	 		 	

 (PC Buyer’s Signature Page to Asset Purchase Agreement) 

  
 -44- 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the day and
year first above written. 
  

			
	BUYER:	 	 HOSPITALISTS MANAGEMENT OF
 NEW
HAMPSHIRE, INC.

		
	 Address for Notice:
  

4605 Lankershim Blvd., Suite 617
	 	  
 Adam Singer, M.D.

President

	 North Hollywood, CA 91602
 Attention: Chief
Executive Officer
 FAX: 818-766-9781
	 	
		
	 with a copy to (which shall not constitute notice):
  

4605 Lankershim Blvd., Suite 617
 North Hollywood, CA 91602

Attention: Vice President of Legal Affairs
 FAX:
818-509-8186
	 	

 (Buyer’s Signature Page to Asset Purchase Agreement) 

  
 -45- 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the day and
year first above written. 
  

					
	SELLER:	 		 	PARK AVENUE MEDICAL ASSOCIATES, LLC
			
	Address for Notice:	 		 	  

	3 Barker Avenue	 		 	Mitchel Kaplan, M.D., President
	White Plains, New York 10601	 		 	
			
	 with a copy to
 (which shall not constitute
notice):
	 		 	
			
	Garfunkel Wild, P.C.	 		 	
	111 Great Neck Road	 		 	
	Great Neck, New York 11021	 		 	
	Attention: Judith Eisen, Esq.	 		 	
	FAX: 516-466-5964	 		 	

 (Seller’s Signature Page to Asset Purchase Agreement) 

  
 -46- 

 IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed as of the day and
year first above written. 
  

			
	OWNERS:	 	 
		
	 Address for notice:
  
	 	  
 Mitchel Kaplan, M.D., as an
individual

	 3 Barker Avenue
 White Plains, New York
10601
	 	
		
	 Address for notice:
  
	 	  
 Mitchell Wolfson, M.D., as an
individual

	 3 Barker Avenue
 White Plains, New York
10601
	 	
		
	 Address for notice:
	 	  
 Daniel Sussman, M.D., as an
individual

	 3 Barker Avenue
 White Plains, New York
10601
	 	
		
	 with a copy for all (which shall not constitute notice) to:
  

Garfunkel Wild, P.C.
 111 Great Neck Road

Great Neck, New York 11021
 Attention: Judith Eisen, Esq.

FAX: 516-466-5964
	 	

 (Owners’ Signature Page to Asset Purchase Agreement) 

  
 -47- 

 EXHIBIT A 

OWNERS 
 Park Avenue
Medical Associates PLLC 
  

			
	 Owner
	  	 Ownership Percentage

	 Mitchel Kaplan
	  	33.3%
	 Mitchell Wolfson
	  	33.3%
	 Daniel Sussman
	  	33.3%

  
 -48- 

 EXHIBIT B 

CALCULATION METHOD FOR PROFIT OF THE EARNOUT BUSINESS 

“Earnout Measurement Period” shall be defined as the first full twelve (12) calendar months following the Closing. 

“Profit of the Earnout Business” shall be calculated as the total revenue (measured on an accrual basis) for the Earnout Business, less
Direct Practice Expenses of the Earnout Business, Local Support Expenses of the Earnout Business, and the IPC Centralized/Allocated Support Expenses, as such expenses are defined in this Exhibit B, minus a baseline (the “Profit
Baseline”) which shall equal: (i) one hundred eighty (180) encounters per day; times (i) the average revenue per encounter for PC Buyer’s Providers in Post-Acute Facilities (as defined herein) within the Earnout
Territory (as defined herein) from September through November of 2013; times (iii) the weighted average contribution margin percentage for PC Buyer’s Providers in Post-Acute Facilities within the Earnout Territory from September through
November 2013. Any EHR-Related Payments shall not be counted in the calculation of the Earnout Payment or Supplemental Earnout Payment or Tuck-in Acquisition Payment. 

“Earnout Business” shall be defined as, during the Earnout Measurement Period or Supplemental Earnout Measurement Period, as applicable: PC
Buyer’s revenues (measured on an accrual basis) in all post-acute Facilities (including skilled nursing facilities, nursing homes, assisted living facilities, adult foster care homes, hospice facilities and programs and other long term care or
residential facilities (“Post-Acute Facilities”), but excluding any short or long term acute care hospitals, inpatient rehabilitation hospitals, and other inpatient specialty facilities) within Massachusetts and Connecticut (the
“Earnout Territory”). 
 Notwithstanding the foregoing, the Earnout Business (and the EHR-Related Payment and Tuck-In Acquisition Payment)
shall exclude any business obtained through acquisition by PC Buyer and/or its Affiliates of Practitioner Support Services, Weintraub Geriatric Associates, New England Inpatient Specialists, and Essex Inpatient Physicians. 

The definition of Earnout Business shall not include any Business in any Facility in which any Owner (or a member of his or her immediate family) or Seller
has an ownership or financial interest, or any referrals to or from any entity in which Seller or any Owner has an ownership interest or financial interest. 

“Tuck-in Acquisition Payment” shall be defined as follows: should PC Buyer and/or its Affiliates (i) successfully close one or more
other acquisitions of either acute-care-focused or post-acute care (in skilled nursing facilities, nursing homes, assisted living facilities, hospices, or adult care homes) focused provider groups in the Earnout Territory (each such entity, an
“Acquired Entity”) during the Earnout Measurement Period or Supplemental Earnout Measurement Period, with the substantial efforts and assistance of one or more Owners; and/or (ii) successfully close one or more acquisitions of
post-acute-care focused provider groups in Upstate New York (each such entity, also an “Acquired Entity”) during the Earnout Measurement Period or Supplemental Earnout Measurement Period with the substantial efforts and assistance
of one or more Owners (any of either, a “Tuck-in Acquisition”); then Seller shall receive a payment from Acquirors (the “Tuck-in Acquisition Payment”) in Immediately Available Funds, calculated as follows: 

  
 -49- 

	 	(a)	The Tuck-in Acquisition Payment for each Tuck-in Acquisition shall be made to Seller at the same time the seller of the Acquired Entity is paid an earnout payment if the relevant earnout measurement period ends prior to
the end of the Supplemental Earnout Measurement Period, or at the time the Supplemental Earnout Payment is made or otherwise would be due to Seller, if the Acquired Entity’s earnout measurement period extends past the end of the Supplemental
Earnout Measurement Period; 

  

	 	(b)	For Tuck-in Acquisitions with an earnout component, the Tuck-in Acquisition Payment for such Tuck-in Acquisition shall be calculated as follows: 

 

	 	1.	If the Acquired Entity’s earnout measurement period is completed before or concurrently with the end of the Supplemental Earnout Measurement Period, the Tuck-in Acquisition Payment for such Acquired Entity shall
equal the profit of the earnout business of the Acquired Entity during its earnout measurement period up to the applicable threshold in such Tuck-in Acquisition multiplied by six and one half (6.5), plus any profit of the earnout business of the
Acquired Entity above the applicable threshold multiplied by one (1), minus the closing payment. 

  

	 	2.	If the Acquired Entity’s earnout measurement period is not completed before the end of the Supplemental Earnout Measurement Period, PC Buyer or its Affiliate shall calculate the annualized profit of the earnout
business of the Acquired Entity, and such calculation shall be based on the actual profit of the earnout business of the Acquired Entity through the end of the Supplemental Earnout Measurement Period. The Tuck-in Acquisition Payment for such
Acquired Entity shall equal the annualized profit of the earnout business of the Acquired Entity up to the applicable threshold multiplied by six and one half (6.5), plus any annualized profit of the earnout business above the applicable threshold
multiplied by one (1), minus the closing payment paid to the Acquired Entity, and the result multiplied by the following ratio: the number of days the Acquired Entity’s earnout measurement period runs concurrently with the Supplemental Earnout
Measurement divided by three hundred sixty five (365). 

  

	 	(c)	For Tuck-in Acquisitions with no earnout component, the Tuck-in Acquisition Payment for such Tuck-in Acquisition shall be calculated as follows: 

  
 -50- 

	 	1.	If the first year following the closing of the Tuck-in Acquisition is completed before or concurrently with the Supplemental Earnout Measurement Period, the Tuck-in Acquisition Payment shall equal six and one half
(6.5) times eighty five percent (85%) of the profit of the business of the Acquired Entity calculated at the end of the first year following the closing, and one (1) times the remaining fifteen percent (15%) of the profit of the
business of the Acquired Entity, minus the closing payment paid to the Acquired Entity. 

  

	 	2.	If the first year following the closing is not completed before the end of the Supplemental Earnout Measurement Period, PC Buyer or its Affiliate shall calculate the annualized profit of the business of the Acquired
Entity, and such calculation shall be based on the actual profit of the earnout business of the Acquired Entity through the end of the Supplemental Earnout Measurement Period. The Tuck-in Acquisition Payment shall equal six and one half
(6.5) times eighty five percent (85%) of the annualized profit of the business of the Acquired Entity, and one (1) times the remaining fifteen percent (15%) of the annualized profit of the business of the Acquired Entity, minus
the closing payment paid to the Acquired Entity, and the result multiplied by the following ratio: the number of days within the Acquired Entity’s first year post-closing that run concurrently with the Supplemental Earnout Measurement Period
divided by three hundred sixty five (365). 

 All such Tuck-in Acquisitions shall be subject to the due diligence process of PC Buyer and/or
its Affiliate(s), and PC Buyer and/or its Affiliates shall not be liable to Selling Group for any delay in the acquisition of any target or proposed group or for the failure to acquire any proposed group. 

“Supplemental Earnout Measurement Period” shall be defined as the thirteenth
(13th) full calendar month through the twenty-fourth (24th) full calendar month following the Closing. 

 

	A.	Direct Practice Expenses 

 Note: This list represents the typical types of expenses
included. Depending on the needs of the acquired Business, additional/other expenses may be involved. 
  

			
	Total salary and benefits	  	Types of Expenses/Comments
		
	Salaries–Physicians	  	All physician compensation, including physician bonuses, signing bonuses, discretionary bonuses, PGL bonuses, guarantees, and stipends from hospitals or other sources
		
	Salaries–Physician Extenders	  	All physician extender compensation including extender bonus distributions, bonus guarantees, and stipends from hospitals or other sources
		
	Salaries–Moonlighters	  	Includes fees for all MLs and/or independent contractors servicing the acquired operations
		
	Salaries–Call coverage	  	
		
	Salaries–Other clinical and direct admin	  	i.e. psychologists, social workers, nurses, medical assistants, care coordinators
		
	Locum tenens costs	  	All locum tenens compensation and related costs
		
	Benefits	  	Employer taxes related to provider salaries, healthcare & other benefit costs, workers compensation, employer 401k match, relocation costs

  
 -51- 

 Other provider-related Expenses 
  

			
	Credentialing	  	Direct costs to be credentialed in facilities or with payers
		
	Communications	  	Cell phones, pagers, answering service
		
	Travel and entertainment	  	Excludes provider travel outside market (e.g. to IPC Leadership Conferences, PGL Meetings)
		
	Marketing expenses	  	Locally generated expenses only (e.g. practice group mailers, lunches)
		
	Office expenses	  	Lab coats, scopes, etc.
		
	Rent expense	  	Rent costs for offices in the hospital/other clinical worksite, if applicable
		
	Education & seminars	  	
		
	Employee functions	  	Functions directly for physicians (including practice group meetings)
		
	CME and Med soc memberships	  	
		
	Legal fees	  	Immigration-related costs or other legal expense directly related to the practice
		
	Charitable contributions	  	Need prior approval from corporate
		
	Malpractice insurance	  	Expenses for the providers in the practice

 NOTE: IPC President and/or designee will collaborate with the leader(s) of the acquired operation in operational decisions.

 IPC President and/or designee are responsible for making final decisions on expenses needed to adequately support operations. 

  
 -52- 

	B.	Local Support Expenses 

 Note: This list represents the typical types of expenses included.
Depending on the needs of the acquired Business, additional/other expenses may be involved. 
  

			
	Description of Expenses	  	Examples/Comments
		
	Exempt salaries	  	Executive Director (ED); Region Directors/Business Directors; Directors of Operations, Recruiters, Office Managers, and/or other exempt employees (all only for the % dedicated to the acquired operation)
		
	Non-exempt salaries	  	Credentialing and other admin assistance, but only for the % dedicated to the acquired operation
		
	Temp help	  	Charges related to the acquired operations
		
	Benefits	  	Employer taxes, insurance benefits, 401k employer match for the % region staff dedicated to the acquired operation
		
	Region admin bonus	  	Formula calculation related to the profit contribution and growth of the acquired operation (distributed to staff who directly support the acquired operation)
		
	Telephone	  	Installation/usage charges for land lines, cell phones related to the acquired operation
		
	Paging services	  	Charges related to the acquired operation
		
	Travel and entertainment	  	Travel/entertainment expenses for admin persons but only for trips related to the acquired operation
		
	Dues and subscriptions	  	Charges related to the acquired operation
		
	Purchased services	  	If needed, local IT support and other professional services related to the acquired operation
		
	Marketing expenses	  	Charges related to the acquired operation (e.g. mailers, lunches), excludes any corporate development expenses
		
	Computer expenses	  	Internet fees, videoconferencing fees, misc computer accessories related to the acquired operation
		
	Office supplies	  	Charges related to the acquired operation
		
	Printing	  	Charges related to the acquired operation
		
	Postage	  	Charges related to the acquired operation
		
	Delivery services	  	Charges related to the acquired operation
		
	Equipment purchases (under $1,000)	  	e.g. cell phones
		
	Equipment repairs and maintenance	  	Charges related to the acquired operation
		
	Equipment rentals	  	Charges related to the acquired operation
		
	Facility Rent expense	  	Any admin office dedicated to the acquired operations
		
	Recruiting	  	Professional outside recruiter fees, if any, related to the acquired operation; costs to entertain such provider candidates (T&E, Hotel, Airfare, etc.)
		
	Education & seminars	  	Charges related to the acquired operation
		
	Meetings	  	Practice or Market meetings for the providers in the acquired operation
		
	Employee functions	  	Charges related to the acquired operation
		
	Business taxes and other fees	  	Charges related to the acquired operation (excludes Federal and state income taxes)
		
	Legal fees	  	Fees related to the specific operations (excludes practice acquisition costs)
		
	Depreciation expenses	  	Depreciation of assets used in the acquired operations (furniture, videoconference and other equipment>$1000, PC’s, etc.)
		
	Charitable contributions	  	Charges related to the acquired operation; need prior approval from corporate

 NOTE: IPC Executive Director and/or designee will collaborate with the leader(s) of the acquired operation in operational
decisions. 
 Executive Director and designee are responsible for making final decisions on expenses needed to adequately support acquired
operations. 

  
 -53- 

	C.	IPC Centralized/Allocated Support Expenses 

  

			
	 Billing/Collections/Technology fee
	  	 Fee not to exceed 4.0% of fee for service revenues, including PCIP revenues and any revenues related to provision of clinical
services under facility agreements (excluding medical director and other similar payments)

  
 -54- 

 EXHIBIT B 

SELLER NONCOMPETITION AGREEMENT 

  
 -55-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00227-of-00352.parquet"}]]